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ABSTRACT OF DISSERTATION

AN ASSESSMENT OF THE CARRIER STATE AND A NOVEL MARKER OF
LEPTOSPIRA AND ABORTION IN CENTRAL KENTUCKY HORSES
Leptospirosis is a reemerging zoonotic infection of worldwide importance
and affects all mammals. The bacterium is transmitted to animals and humans
by urine, fetal membranes and body fluids. Leptospira shedding in the urine
contaminates both soil and water, exposing both humans and animals to the
bacterium. Leptospirosis in horses can cause abortion and is one of the
etiologies of equine recurrent uveitis which can lead to blindness. Equine
leptospiral abortion in Central Kentucky is primarily caused by serovar Pomona,
with occasional cases attributed to serovar Grippotyphosa. There are a few
reports in the literature attributing abortion to serovar Bratislava in the United
States. Interestingly, Bratislava has the highest seropositivity in the horse in the
United States.
Two studies were conducted that are included in this dissertation. The first
was to determine the prevalence of leptospirosis in horses located in Central
Kentucky submitted for necropsy to the University of Kentucky Veterinary
Diagnostic Laboratory. Heart, vitreous humor, kidney and urine samples were
collected for microagglutination testing (MAT) and real-time PCR (qPCR). Heart
blood and vitreous were tested using MAT for serovars Grippotyphosa, Pomona
and Bratislava. Kidney, vitreous and urine samples were tested for pathogenic
Leptospira by qPCR. MAT test results for heart blood indicated an increased
seroprevalence for Bratislava as compared to Grippotyphosa and Pomona.
Three horses had positive titers for serovar Bratislava in vitreous and heart blood
samples. All urine samples tested negative by qPCR, and only one kidney
sample had a weak positive result. Four vitreous samples tested positive for
leptospirosis by qPCR, but all samples were negative upon MAT testing. No
samples with positive MAT titers were positive by qPCR for any of the samples
tested. Females were more likely to have positive MAT titers and were
considerably older than males. MAT titers in females were also significantly
higher as compared males. Finally, there was widespread seroprevalence in
horses, regardless of the reason for necropsy submission. This suggests that

exposure to Leptospira on Central Kentucky horse farms is common and the risk
of exposure to humans and other animals is possible.
The second study evaluated the enzyme heme oxygenase-1 (HO-1) and
its potential as a marker for abortion in pregnant mares with elevated MAT titers.
HO-1 is the rate-limiting step in the breakdown and degradation of heme to
carbon monoxide, free iron and biliverdin, which is converted to bilirubin.
Increased levels of HO-1 and its’ by-products are upregulated during
inflammation and sepsis. HO-1 together with its by-products are essential in
protecting the body from both increased inflammation and in reducing the risk of
sepsis in humans, mice and rats. HO-1 together with its by-products are also
essential in helping maintain pregnancy in humans, mice and rats. HO-1 in the
serum of horses has not been previously investigated. The presence of HO-1 in
the serum of healthy non-pregnant mares (NPM), pregnant mares throughout
pregnancy (PMOT), pregnant mares ≥7 months pregnant with and without
placentitis (PM) and pregnant mares with high MAT titers (MATS) was
investigated. HO-1 levels in both NPM and PMOT were lower than PM, and
significantly lower than MATS. Pregnancy alone increased HO-1, the same has
been shown in other mammals and humans. Additionally, mares pregnant with
elevated leptospiral titers had significantly higher HO-1 levels compared to other
mares. This indicates that both pregnancy and high MAT titers increase the
animals’ HO-1 response. Further investigation of HO-1 in horses is needed to
ascertain its’ importance during infection and/or pregnancy and potential
therapeutics.
KEYWORDS: Leptospirosis, Horses, Serovars, Heme Oxygenase-1, Pregnancy
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Chapter One
Literature Review
1.1 Introduction
Leptospirosis is a zoonotic infection of global importance. Once thought to
be contained, it has emerged as one of the most widespread zoonotic diseases
in the world [1-3]. It is readily propagated from animal to animal and animal to
man; however, human-to-human transmission is rare. Leptospirosis is a major
public health concern in South America and South East Asia and is now
considered a re-emerging disease in most developed countries [2, 4]. An
estimated 1 million people are infected worldwide annually, leading to over
59,000 deaths [5].
Leptospira spp. are found in over 160 mammals worldwide, including
dogs, cats, ruminants, horses and sea lions [6-8]. Multivalent vaccines only exist
for dogs, swine and cattle. A monovalent vaccine for serovar Pomona became
available for the horse in the United States (US) in the fall of 2015. Vaccine
availability is limited to a small number of species, allowing the spread of this
disease in other mammals and humans in many countries, which can lead to a
public health crisis. Appendix 1 contains two tables. Table One is a list of
available vaccines, serovars and species by pharmaceutical company available
in the US. Table Two is a list of available vaccines, serovars and species by
pharmaceutical company available outside the US.
The prevalence and economic impact of leptospirosis in humans are not
well documented. However, leptospirosis is estimated to infect millions of
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humans annually with case fatality rates ranging from 5 to 25% [9]. The highest
occupational risk for contracting the disease either through direct contact (urine
or body fluids) or indirect contact (contaminated water or soil) are veterinarians,
farmers, slaughterhouse workers, butchers and sewer workers [3, 10-12]. Many
outbreaks have been related to floods caused by high rainfall events. Clinical
illness in both animals and humans can result in economic losses through lost
wages, medical and veterinary bills, loss of animals and quality of life.

1.2 Leptospirosis
Leptospirosis is caused by a gram-negative bacterial spirochete in the
order Spirochaetales, family Leptospiraceae and genus Leptospira.
Leptospirosis was first described in 1886 by Adolph Weil and demonstrated by
A.M. Stimson in 1907. The first isolation in pure culture was achieved by
Japanese scientists, led by Ryokichi Inada in 1914 [13]. Leptospires are 0.1-0.2
µm in diameter and range from 6-25 µm in length [14]. There are both pathogenic
and saprophytic species [6, 12].
Spirochaetales contain three families: Brachyspiraceae, Leptospiraceae
and Spirochaetaceae [7, 14]. Both Borrelia and Treponema (cause of Lyme
disease and syphilis respectively) also belong to the Spirochaetales order.
Leptospires are unlike other members of the order in that they contain terminal
hooks. They are highly motile by virtue of two periplasmic flagella located at
each end, which allow the organism to burrow into the tissue [6]. Leptospires are
obligate aerobes and demonstrate characteristics of both gram-positive and
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gram-negative bacteria [6, 14]. The outer envelope is composed of an antigenic
mucopeptide and a lipopolysaccharide (LPS). The LPS is very similar to those
found in other gram-negative bacteria. However, it has a significantly lower
endotoxic activity compared to typical gram-negatives.
Visualization of the organism is only possible by dark-field or phasecontrast microscopy. This is because the bacteria are extremely thin, also
influencing the poor gram-staining characteristics of leptospires. [6, 14]. Further,
leptospires are difficult to grow in culture and require several additives for
enrichment [6, 14, 15]. The pathogenic species are heat sensitive; they can
tolerate temperatures between 00-250C but not well above 42˚C. They are
inactivated at temperatures below freezing or above 55˚C. Saprophytic
Leptospira are ubiquitous in fresh water and soil [16, 17]. Only pathogenic
leptospires have the genetic capability of utilizing cobalamin through autotrophy
[18]. The autotrophic ability of pathogenic leptospires possibly allows it to infect
mammals despite the host’s ability to sequester cobalamin [18, 19]. Pathogenic
leptospires also have a complete folate biosynthetic pathway whereas
saprophytes do not [18]. This allows pathogenic leptospires the ability to survive
in a nutrient poor locale within the host.
The incidence of leptospirosis in humans is underestimated due to several
factors. First, the disease mimics many commonly occurring viral and bacterial
infections such as influenza, Dengue, rickettsial infections, viral hepatitis,
brucellosis and malaria [15, 20]. Second, leptospiral clinical infections can be
short and self-limiting, with typical symptoms of fever, headache, nausea,
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vomiting and abdominal pain [6, 9]. Early in the disease presentation,
misdiagnosis is common. For subacute and chronic cases, liver and kidney
failure (16-40% of cases), and respiratory complications (range from 20-70%)
can occur. Other reasons for underestimation of the disease are general lack of
clinical curiosity by healthcare professionals and a shortage of diagnostic
laboratories with validated methods for leptospiral testing. Finally, human
infections commonly occur in developing countries that are unlikely to have
diagnostic laboratories for rapid disease confirmation.
Leptospirosis is known to occur extensively in various mammalian
species; however, it is typically confirmed in cattle, swine and dogs [6, 14, 21].
Bats have been diagnosed with leptospirosis but their ability to transmit
leptospirosis to humans and other mammals is considered rare [22-24]. In
humans and animals, the portal of entry for the bacteria are cuts and abrasions in
the skin, conjunctiva and mucous membranes. Another portal of entry is via
ingestion of contaminated water or food [9, 12]. While the potential for birds as
carriers of leptospires has been investigated, early research studies did not yield
evidence of leptospiral infections [25]. However, a recent article demonstrated
five different types of birds in Botswana with 27.8% renal positivity by PCR [26].
Further studies are needed to characterize the leptospiral carrier state of birds as
they could provide another mode of transmission of leptospirosis.
Animals can become chronic carriers of leptospires once they have
recovered from the acute phase of the infection. This allows the disease to
perpetuate in nature posing a risk to humans and other animals [6, 21].
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Leptospires can survive and propagate in renal tubules, can remain viable for
years and are passed by urine into water and soil. In some species such as
bovine and swine, shedding is intermittent, making carriers difficult to detect [6, 9,
15, 21]. In humans, leptospires in the urine typically present the first week after
clinical signs are seen [6]. Leptospires can be difficult to identify by culture or
molecular methods due to inhibitory substances and the acidic pH of the urine in
some species, whereas alkaline urine can foster the persistence of leptospires
[9]. Table 1.1 lists the urine pH of several species. Urine also tends to be
‘contaminated’ with multiple microorganisms which may inhibit isolation of
leptospires [27].
Table 1.1: Urinary pH Range by Species
Species
Urinary pH Range*
Bovine
7.0-8.4
Ovine
7.5-8.5
Caprine
7.5-8.5
Equine
7.6-9.0
Canine
5.5-7.0
Rabbit
8.2
Humans
4.6-8
*[28]
Leptospires are trophic for renal tubules but they can also remain viable in
the genital tract, brain and eye. Indirect modes of transmission of leptospirosis is
by contact with contaminated urine, water or soil, making the risk of
environmental exposure dependent on various factors. A temperate climate and
a slightly alkaline pH, moderate to excessive rainfall can increase survival time of
leptospires in the environment [15, 29, 30]. Other factors such as pH of soil can
range from 4.0-8.0 depending on vegetation, moisture and soil age [31].
Inhibitors in soil and water such as competition with other microorganisms and
5

fungi can reduce the survival time [31, 32]. Survival time in the environment
range from hours to months depending on the conditions [15, 32].

1.3 Diagnostics
Due to non-specific clinical signs, a leptospirosis diagnosis requires
laboratory confirmation. The classical method is aerobic culture of the organism
from spinal fluid, uterine fluid, aborted fetuses, kidney, placenta, blood or urine.
Leptospires can also be isolated from liver, spleen and lung specimens. The
culture medium, Ellinghausen-McCullough-Johnson-Harris (EMJH), is commonly
used to isolate leptospirae from animal samples. Selective inhibitors such as
antibiotics, bovine serum albumin and Tween 80 can be utilized to help promote
the growth of leptospires. EMJH base media and enrichment additives are listed
in Appendix 2. EMJH media contains either 10-15% rabbit serum or 1% bovine
serum albumin along with long-chained fatty acids, vitamins B1 and B12 are
required for growth. Typically, the generation time of saprophytic leptospirae is
five hours, whereas pathogenic strains require about twenty hours [33]. The pH
of the media is maintained at between 6.8-7.4 with an incubation temperature of
28-30oC. Some leptospirae can take anywhere from a few days to a month to
grow. Primary cultures grow very slowly and should be retained for 13 weeks
with no growth to be considered negative [12, 14]. Once growth is established in
culture, the organism can stay viable for up to ten years in Korthof’s medium
(10% hemolyzed rabbit serum, 0.08% Neopeptone and 0.14% NaCl buffered to
pH7.2) [9, 16]. Certain species require additional additives for growth such as
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glycerol, pyruvate and carbon dioxide [6, 14]. A new culture medium, HornsbyAlt-Nally (HAN) has been developed for growth at 37oC instead of 30oC [34]. The
medium has only been tested with two strains (strains IC:20:001 and HB15B203)
of Leptospira, and further testing is needed with other strains. The advantage of
this medium is growth at 37oC which is more compatible with in vivo
temperatures and laboratory instrumentation [34]. The formulation for this
culture medium is listed in Appendix 2. Culture and identification is difficult and
time-consuming, especially if samples are not taken within the first week after
clinical signs occur [7]. Further, samples should be collected prior to antibiotic
therapy. Treatment with antibiotics can reduce the viability of leptospiral and
other organisms present in the specimen making the organism more difficult to
isolate. Antibiotics can also reduce serological titers when given early in the
infection of dogs [6]. Due to the difficulty of culturing leptospirae, most diagnostic
laboratories do not stock EMJH culture media.
Other laboratory methods are used in both humans and animals for
diagnosing leptospirosis, all with limitations. The microscopic agglutination test
(MAT) is considered the ‘gold standard’ for serological testing because of its high
sensitivity and specificity, 92% and 95% respectively. However, this method
requires a high level of technical proficiency, leading to low precision across
laboratories [6, 7, 15, 35, 36]. Further, the MAT method requires the use of live
organisms, adding a slight risk to laboratory workers that handle them.
MAT antibodies are not detectable until six or more days after
exposure/infection occurs, with peak titers occurring typically by the fourth week
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after exposure. Paired serum samples (acute and convalescent) with a four-fold
increase in serum titers after 10 days, indicate an active leptospiral infection, with
or without clinical signs [6]. Titers of greater than ≥800 in endemic areas along

with symptoms of disease in humans are indicative of current or recent exposure
or infection. In a seven-year study, patients diagnosed with leptospirosis were
monitored in an endemic area of Barbados [37]. Blood samples for MAT titers
were acquired during the acute and convalescent phases, and then annually for
seven years. High titers (1600-3200) were observed up to 4 years postconvalescence. Seroprevalence was detected in most samples during the entire
study (Table 1.2). This study indicates humans can be seropositive for an
extended period. Additional environmental exposure (quantity and number of
exposures in a timeframe) can increase the seropositivity. Titers of ≥800 can
sometimes indicate active disease. Therefore, additional tests are needed to
confirm cases of leptospirosis. Additional papers have shown similar
seroprevalence persistence [38, 39].
Table 1.2: MAT Titers During Acute and Convalescent Phases in Humans*
%
Maximum
Maximum MAT
Titers MAT Titer
%
Titer
Serogroup
≥ 𝟖𝟖𝟖𝟖𝟖𝟖
End of
Seropositive
(per cent
End of
Study
End of Study
seroprevalence)
Study
Ballum
25,600 (90%)
0
400
60%
Icterohaemorrhagiae 51,200 (86.8%)
0
400
75%
Autumnalis
51,200 (95%)
8.7
800
60.9%
Australis
51,200 (54.9%)
2.3
800
16.3%
*[37]
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Interestingly, some serovars generate low titers of 100 or less even when
infection is present, especially in nonendemic areas [33, 40]. In general, the
serovar with the highest titer is considered to be the infecting serovar whereas
serovars that have lower titers are thought to be cross-reactions [6]. Cross
reactions in humans with other bacteria have occurred with MAT in patients with
syphilis, relapsing fever, Lyme disease and legionellosis [40]. Cross reactivity in
animals to other bacteria has not been reported [41, 42].
Vaccinated dogs can have an increased titer from 3-6 months following
vaccination [6, 43]. Titers in vaccinated dogs are rarely over 300, however titers
of 3200 have been seen. Post-vaccination titers can increase (anamnesis)
when natural environmental exposure occurs [43]. In one study, when postvaccination titers were measured in cattle, titers as high as 12,800 were seen
and remained high (800) 4 months after vaccination [44].
Other serological tests used are the immunoglobulin M (IgM)-enzymelinked immunosorbent assay (ELISA), IgM dot blot, indirect hemagglutination
assay (IHA), IgM dot-ELISA dipstick, macroscopic slide agglutination test,
immunofluorescence and radioimmunoassay. All these tests have their
limitations such as: varying degrees of sensitivity/specificity for early diagnosis
(IgM-ELISA and dot blot, IHA); lack of laboratories capable of performing these
tests especially in developing countries (RIA and immunofluorescence) and
some detection only to genus level (IgM). The use of the IgM based tests have
become readily accepted as alternatives in laboratories for aiding in confirming a
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diagnosis of leptospirosis, especially with the introduction of kit-based
diagnostics [6, 15, 33, 40, 45, 46].
Globally, the use of PCR for diagnosis of leptospirosis is becoming
common. But, as with the MAT method, technicians must be highly trained and
undergo regular proficiency testing to assure accurate results. In addition, the
cost of equipment, kits, and hardware maintenance is high, limiting the use of
these methods in developing countries. PCR-based analysis is used for early,
efficient and rapid diagnosis, based on either the 16S ribosomal ribonucleic acid
(rRNA) or 23S rRNA [15, 33, 47-50]. Several methods such as PCR, real-time
PCR (qPCR) and nested PCR isolate deoxyribonucleic acid (DNA) using blood,
urine or serum for detection, although tissue and cerebrospinal fluid can be used.
All these methods utilize primers specific to pathogenic Leptospira. However,
they differ on the quantification and sensitivity parameters. PCR has been
commercially available for over three decades [51]. PCR is widely used to detect
leptospires and is more economical compared to qPCR, however not as sensitive
and more time consuming [52, 53] . Nested-PCR uses two sets of primers in
successive runs, where the second set of primers amplifies an area within the
first product [54]. Nested-PCR is more sensitive than PCR but takes more time
and increases risk of false positives through amplification of contaminants. Realtime quantitative PCR calculates fluorescent signals after each cycle to
determine amount of signal at specific times [51]. qPCR is more sensitive,
reproducible and requires less time than both PCR and nested-PCR [51, 55].
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The disadvantage of using the 16s or 23s rRNA is it will detect both the
non-pathogenic and pathogenic Leptospira along with any other bacteria.
Specific primers to the LipL32 outer membrane protein, which only pathogenic
Leptospira have, is necessary to determine whether active infection is present.
The disadvantage of PCR based methods is the need to have specific primers for
each individual serovar, especially when desired for epidemiologic studies.
Multilocus sequencing (MLST) is a PCR based method used in differentiating
serogroups for epidemiological studies [56]. MLST uses PCR and sequencing to
determine targeted genes. MLST is robust especially in determining specificity
and sensitivity [55, 57]. A drawback to MLST is high-cost equipment needed
along with the necessary expertise in running and evaluating the testing data.
Additionally, MLST research has been focused on pathogenic Leptospira with
limited knowledge of the biodiversity found in the environment [58]. An emerging
molecular analysis is whole-genome sequencing (WGS) for both epidemiological
and strain typing [58]. WGS utilizes MLST along with core genome and as this
method is further developed it will lead to a more comprehensive characterization
of Leptospira. In 2018 the genus Leptospira was updated with the addition of 35
new species and divided into three phylogenetic clusters correlating to their
pathogenicity: saprophytic, intermediate and pathogenic [59]. In these three
clades there are 13 pathogenic species, 11 intermediate species containing over
260 serovars, whereas the saprophytic group contains 11 species and over 60
serovars. The use of WGS restructured the Leptospira genus in 2019 with the
addition of 31 new species [58, 60]. Two major clusters of pathogenic species
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were further divided into 2 subclusters called P1 and P2. The P2 subcluster now
contains the intermediate species and the saprophytes, which were further
divided and named S1 and S2.
Proper collection and storage of samples for successful isolation of DNA is
crucial. Whole blood or plasma are superior to serum for detection of leptospires
by PCR. This is due to the organism ‘sticking’ to either/or white blood cells
(WBC) and red blood cells (RBC) [47]. Only EDTA or sodium citrate should be
used as an anti-coagulant as heparin will interfere with downstream PCR and
sequencing. Ideally, urine samples should not be collected until the second or
third week after suspicion of a Leptospira infection (i.e. compatible signs and test
results) are detected, when shedding in urine is most likely [47]. Once collected,
it must be kept on ice until it can either be refrigerated or frozen to decrease
enzymatic breakdown.
Additional molecular methods such as pulse-field gel electrophoresis
(PFGE), randomly amplified polymorphic DNA, amplified fragment length
polymorphism (RFLP), multi-locus variable number of tandem repeats analysis
and multilocus sequence typing have shown promising results [15, 33]. The use
of PFGE is considered the gold standard for the molecular identification of
leptospires. All these tests require very specific training, can be labor intensive,
and are typically performed only in larger diagnostic or research laboratories.
However, the use of molecular techniques in conjunction with MAT has become
the gold standard for the diagnosis of leptospirosis.
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1.4 Environmental Effects on Incidence of Leptospirosis in Mammals
Evidence is mounting that select zoonotic diseases might be exacerbated
by climate change [61, 62]. Earth’s land and oceanic temperatures are
increasing which has impact on the microbiome of ecosystems. Microbes can
adapt to higher temperatures. Increasing environmental temperatures may
select for heat tolerant microbes [61]. Climate change is thought to be a factor
leading to increased spread of zoonotic infections. Microbes adapt and migrate
with humans and animals to new environments [63]. When people move within a
country or migrate to a new one, they are carrying microbes along with them and
are also exposed to ‘foreign’ microbes at the new location. Examples of climate
change include alterations in precipitation patterns, leading to increased
wildfires, hurricanes and tornadoes [62]. Often, people are forced to relocate
because of climate change. For example, in the western US, wildfires and
flooding in the southeast have forced people to move (Figure 1.1) [64-66].
Figure 1.1: Population Movement Based on Climate Change Issues

Booth, M. Adv Parasitol. 100: 39-126, 2018.
13

Globally, temperatures have increased 1.70F since 1890 [67]. Figure 1.2
depicts the global rise in temperature. The previous ten years have been the
warmest recorded since 1884.
Figure 1.2: Global Temperature Rise from 1880-2020

Precipitation, on average, has increased globally over the past century.
The total area of Arctic ice has decreased overall by ~13.4% since 2010,
increasing ocean levels [67]. These environmental changes have promoted
zoonotic infections to be endemic in locations previously not reported. Further,
microbes will adapt to higher temperatures and increased precipitation,
encouraging mutations posing increased risk for humans [61, 63]. The increase
in global temperatures over the last 30 years, has doubled the number of
survival days in the environment for Vibrio spp. [68].
Environmental conditions (precipitation, temperature, soil pH, soil
microorganisms, bodies of water, and wildlife) play a part in the survival of
leptospires in the environment [17, 30, 32, 69, 70]. Increases in both
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precipitation and temperature have been implicated in increased incidence of
leptospirosis in both animals and humans [6, 15, 30]. In a 16 year retrospective
study of weather data, precipitation was found to increase the incidence of
leptospirosis in horses more so than temperature [30]. Both precipitation and
temperature combined resulted in increased incidence above precipitation alone
[30]. In the US, there has been increased rainfall and temperatures in the
Northeast, along with major flooding events and heatwaves in the Midwest over
the past 20 years. The average annual precipitation worldwide has increased at
a rate of 0.08 inches/decade since 1901 [71]. In the Bluegrass region of
Kentucky, a record 76 inches of rain was recorded in 2018 [72]. It is well known
that Leptospira flourish in temperate climates with moderate to increased rainfall
[30].
In a 2019 article from the Pasteur Institute, leptospirosis was the only
bacterial disease predicted to have increased incidence/prevalence related to
climate change across Europe [73]. This can be seen by increases in global
flooding destroying crops and increasing rodent populations, leading to outbreaks
of leptospirosis [74].
There has been insufficient research in the survival of leptospires in soil.
Recent studies have shown soil may have a significant role in the persistence of
leptospires in the environment [17, 32]. Leptospires can survive for long periods
of time in moist soil with organic matter [75]. Research has demonstrated a
higher incidence of leptospires in soil compared to adjacent reservoirs of fresh
water [69, 75]. Various soil samples have a greater diversity and concentration
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of both non-pathogenic and pathogenic Leptospira compared to water [59, 60,
76]. The complexity of soil and extensive growth period of Leptospira in vitro has
made it difficult to culture the organism, but with the advent of multi-sequencing
genomics additional information is being discovered [17]. Genomics has
advanced knowledge regarding leptospires in the environment. It is now
believed leptospires are retained in the soil and with increased rainfall are
flushed into adjacent waterways and standing water [17, 32, 77]. Soil nutrients
also may influence the survival of leptospires in the soil. One study
demonstrated that soil with high levels of copper, iron and manganese had a
higher concentration of Leptospira than in soil with lesser concentrations of these
elements [78].
Seasonality helps to determine the species detected in the environment.
In Chile, L. kirschneri was more common in the spring, whereas L. interrogans
occurred more often in the winter [79]. Leptospiral species prevalence could be
due to seasonality changes in wildlife populations. A study in New Caledonia
found species changes in the black rat, from L. interrogans in the winter season
to L. borgpetersenii during the hot rainy season [80].
Biofilms in conjunction with climate change may also be important in the
survival of Leptospira in the environment. The first description of Leptospira
biofilms was in 2008 [4]. In vitro experiments found saprophytic leptospires take
5 days or less to form biofilms, compared to an average of 20 days for
pathogens. Additionally, saprophytic leptospires were able to form biofilms at 21,
30 and 37OC whereas pathogenic occurred only at 30 and 37OC, in liquid culture.
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The ability of leptospires to form biofilms in nature allows them to survive in a
multitude of environments. Studies have shown a communal relationship with
other organisms in soil and aquatic biofilms [81-83]. Leptospires were once
thought to exist in nature alone however biofilms allow them to exist in a
protective environment for longer periods of time [4, 59]. The protection of
biofilms increases the time for animals and humans to become exposed to
leptospires. Leptospira biofilms have also be shown to occur in vivo [84, 85].
Further investigations are needed to ascertain the importance of biofilms
regarding the pathogenesis of leptospirosis.

1.5 Epidemiology of Leptospirosis
Leptospirosis is found in every continent, except for the earth’s polar
regions [86]. Detecting and tracking outbreaks is difficult because of the
complexity and cost of making a definitive diagnosis of leptospirosis. In addition,
clinical presentations vary, physicians may lack suspicion and knowledge
regarding the pathogenesis and epidemiology of the disease.
In temperate climates, leptospirosis occurs more often between June and
early fall. In the United States and Canada, it occurs more frequently in late
summer through January [6, 87, 88]. In the semitropical portions of the United
States, an increase of canine leptospirosis if often seen more in late summer and
early fall [6]. Outbreaks of leptospirosis increase in warmer temperatures
following periods of heavy rainfall and when flooding occurs [11, 15, 89].
Leptospires are unable to replicate outside the host, however they can live and
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replicate in invertebrates and insects, though the importance of this as it relates
to the transmission of leptospirosis is unknown [6, 90]. Leptospirosis is
designated as a reportable disease by the European Union [91]. Because of its
ubiquitous nature, surveillance for both human and animal cases of leptospirosis
is recommended throughout the world. [20].
There are two categories to describe hosts of leptospirosis, maintenance
and accidental [6]. In animals, a maintenance host generally means that the
infection is endemic and is transmitted from animal to animal through direct
contact [11, 89]. Leptospires are usually acquired at a young age, with lifelong
shedding of the organism in the urine common [6]. The degree of shedding
tends to increase with age. Rodents, and domestic animals such as dogs, cows
and pigs, are considered as key maintenance animals. Some serovars have
more than one primary host. However, serovars such as Icterohaemorrhagiae
are primarily associated with rats and Hardjo with cattle [92].
Accidental hosts, which includes humans, are infected by indirect contact
with the bacteria in water (either through drinking or recreational exposure), soil
or through direct contact of urine or reproductive fluids, often during occupational
exposure [6] [11, 21].
There are various factors that influence the maintenance of leptospires in
the environment and the spread of leptospirosis in both humans and animals. It is
no surprise that a higher incidence is found in developing countries. Factors
such as age, socioeconomic status, access to clean water, crowding, medical
care, prior health status, nutrition and lack of diagnostic tools, along with lack of
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rapid and accurate laboratory identification all play a role in prevalence and
spread of the disease [6]. Many physicians are not well-trained in zoonotic
diseases such as leptospirosis and often will not consider leptospirosis in their
differential diagnosis list [20]. The incidence of leptospirosis for animals and
humans is higher in developing countries with an extensive agricultural base.
Whereas in developed countries, agriculture may have a role, but to a lesser
extent.
In 2008, an outbreak in Sri Lanka resulted in 3,825 cases (JanuaryAugust 2008) of leptospirosis in humans with 33 deaths reported in a three-week
period [93]. In October 2009, an outbreak of leptospirosis occurred in the
Philippines after heavy rains from a tropical storm [94]. There were over 2,000
human cases with 167 deaths within a month after the flooding had occurred. In
Ireland there was an increase in human leptospirosis cases, 22 occurring in 2007
and 30 cases in 2008 with 17 hospitalizations and one death [95, 96]. The cases
in Ireland occurred primarily through agricultural exposure and participation in
watersports. In the previous 5 years there have been 96 postings on ProMedMail regarding cases of leptospirosis throughout the world [97]. In 2014, 239
active military members became ill after exposure to pond water on a marine
base in Okinawa, Japan [98]. In September 2017 after Hurricane Maria in Puerto
Rico, outbreaks occurred in both humans and domestic animals [99]. Increased
cases in Puerto Rico are thought to be linked to lack of access to clean drinking
water. During the months of June-August 2018 an outbreak occurred in northern
Israel [100]. Over 600 people were diagnosed with leptospirosis, and 146
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hospitalized with a history of swimming in both natural springs and streams. The
global burden of leptospirosis cases in humans in 2015 is depicted in Figure 1.3.

Figure 1.3: Human Global Burden of Leptospirosis
(DALYs*/100,000/year)

*Disability Adjusted Life Years
[101]
In developed countries, exposure can occur during recreational activities
and in urban areas with high rodent populations [6, 21, 102]. Table 1.3 lists
several human outbreaks of leptospirosis in the past two decades in the US.
Urbanization can lead to an increased prevalence of leptospirosis. In a
retrospective study conducted in Indiana 1997-2002, increased prevalence of
leptospirosis was detected in dogs in once rural areas which been had become
urbanized over the past 10 years [92]. Outbreaks of leptospirosis occurred in
Illinois in 1998 after a triathlon and again in 2005 in Florida. The triathlon
involved a trek through a marshy area [103]. In one case, an infant contracted
the disease after nursing a mother who was infected with leptospirosis. There
have also been several cases of transplacental leptospirosis with subsequent
abortion in humans [104, 105].
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Table 1.3: Recent Outbreaks of Leptospirosis in Humans in US
Year
City/Area Numbers Possible
Affected
Cause
1
1993Baltimore 3/3
Rats
1998
(100%)
1997Indiana2
19/30
Multiple
2002
(63.3%)
exposures
3
1998
Illinois
52/474
Triathlon
(11%)
1974Hawaii4
353 cases Multiple
1998
exposures
2005
Florida5
14/31
Triathlon
(45%)
1
[106]; 2[92]; 3[107]; 4[108]; 5[103]
Humans or animals that have been exposed or have recovered from
leptospirosis develop an acquired immune response which can help protect
against future infections of the same serovar. Immunity generated by exposure
to one serovar is generally not cross-protective for other serovars [6, 7].
Recent studies have shown seroconversion in humans to Leptospira
positive animals. A study conducted in 2010 demonstrated seroconversion to
leptospires by practicing equine veterinarians and horse farm workers located in
Central Kentucky for the first time [30]. Veterinary students in Trinidad showed a
higher seroconversion to Leptospira than non-veterinary students [109]. In New
Zealand veterinarians attending a conference volunteered to be tested for
leptospiral antibodies. Over 5% of those tested showed a seroconversion [110].
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1.6 Clinical Leptospirosis in Humans
Leptospirosis in humans mimic flu or flu-like diseases such as dengue and
malaria [15, 35, 111]. Presentation of the disease in humans range from
asymptomatic to severe. Typically, symptoms begin within a few days after
exposure, but can take up to four weeks to occur [12, 14]. Fever tends to be
biphasic and may last up to nine days, followed by several afebrile days before
the fever reappears. Once the leptospires enter the body, they soon move into
the blood stream and infect multiple organ systems such as liver, spleen,
kidneys, central nervous system, genital tract and eyes, causing various lesions
[14, 36]. These lesions are thought to be caused by leptospiral toxin(s) or toxic
cellular components that damage the endothelium of small blood vessels,
triggering localized ischemia in organs. This leads to hepatocellular damage,
renal tubular necrosis and myositis. In severe cases hemorrhage can occur
along with platelet insufficiency and jaundice.
Leptospirosis manifests itself in two distinct phases. The first phase
involves fever, chills, vomiting and/or diarrhea, myalgia and headache. A rash
may occur on the skin and palate [14]. Chronic uveitis may also occur typically a
year after the initial infection [112]. Symptoms usually abate within several days
but may continue for 3 weeks or longer. Relapses can occur and often lead to
kidney and/or liver failure, myocarditis, mucosal hemorrhage or meningitis [6, 12,
14]. The second phase is referred to as Weil’s disease named after Adolph Weil,
a German physician who first described leptospirosis. Mild to severe illnesses in
humans are caused by serovars Hardjo, Grippotyphosa or Pomona. However,
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serovars Copenhageni and Icterohaemorrhagiae are typically the ones that result
in the most severe illness. The severity of the disease depends on the organ
systems infected. The serovars that cause illness vary from country to country,
making it difficult to develop a generic vaccine to protect humans from
leptospirosis. In addition, new serovars can emerge. One study revealed the
emergence of new serovars on the islands of American Samoa [113]. These
serovars (Hebdomadis, LT 751, LT 1163) are suspected to have caused chronic
leptospirosis with systemic illness. Mortality can be as high as 25% in untreated
cases within two weeks of symptoms. However, deaths have been reported as
early as five days subsequent to initial symptoms in severe cases [114].
In 1994, leptospirosis was removed from the Center for Disease Control
(CDC) list of notifiable disease in the United States since incidence in humans
had been declining [115, 116]. Furthermore, testing for leptospirosis was not
readily available by medical laboratories throughout the US. As a result, many
states were not reporting and likely underestimating prevalence. In addition
other emerging diseases required placement on the notifiable disease list, taking
the place of leptospirosis [117]. In the late 1990s, outbreaks of recreational
human leptospirosis in the US prompted the Council of State and Territorial
Epidemiologists to reinstate leptospirosis as a notifiable disease in 2012 [20,
108]. Leptospirosis was placed back on CDC list of notifiable diseases in 2013.
Leptospirosis outbreaks are posted as part of the National Outbreak Reporting
System on the CDC’s website [118]. Increased incidence of human leptospirosis
outbreaks has been seen over the past several decades, mostly occurring at
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recreational lakes [115, 119]. In the 1980s and 1990s outbreaks also occurred in
poor metropolitan areas of Detroit and Baltimore [6, 115, 117, 119].
Human leptospirosis is treated using antibiotics such as penicillin,
erythromycin or doxycycline, and most effective when given early in the course of
the disease [6, 12, 114, 120]. Even though the acute disease can be selflimiting, 5-10% of cases lead to severe illness, thus most physicians initiate
treatment with antibiotics to try and clear the infection. Numerous studies have
shown the duration of the disease is decreased when antibiotics are
administered following the onset of symptoms [6, 114]. Managing symptoms
through supportive care such as bed rest, analgesics for headaches and muscle
pain, antipyretics for fever and intravenous fluids where indicated, will help in
minimizing disease progression, leading to a positive outcome.

1.7 Animals-Epidemiology and Geographic Distribution of Leptospirosis
Leptospiral infections in animals present as a peracute, acute, subacute,
or chronic infections, with a range of signs from gastrointestinal, respiratory,
ocular, reproductive, renal and hepatic [6]. The signs and duration vary
dependent on species.

1.7.1 Clinical Leptospirosis in Canines
The classic presentation is vomiting, diarrhea, fever, jaundice, uremia
secondary to renal failure, disseminated intravascular coagulation (DIC),
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hemorrhage and death [6, 121]. The incidence of canine leptospirosis in the US
has increased over the past 25 years [122]. Increased incidence has been
reported in Ohio, Florida, Michigan, Texas, Illinois, New York, California,
Massachusetts and most recently Utah in 2019. In September 2019, Utah
reported over 12 dogs diagnosed with leptospirosis [123]. A study published in
2017 shows the number of positive canine MAT tests in the US between 20002014 (Figure 1.4) [122]. Positive MAT tests increased from 8.7% to 12% from
2002 through 2004.
Figure 1.4: Results of Positive Canine MAT Tests by County in
US Between 2000-2014 (Counties without indicated data had
no MATs submitted to reference laboratories)*

*[122]
The increase in cases could potentially be due to decreased vaccination
for leptospirosis in dogs [124]. In 2011 the American Veterinary Medical
Association, (AVMA) reported <4% of dogs had been vaccinated against
leptospirosis [122]. Conceivably, with the increased use of dog parks and
daycare, this may increase the risk of exposure, especially when dogs are not
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routinely being vaccinated. The urbanization of rural areas increases contact of
humans, dogs and other domestic animals to wildlife, many of which can shed
leptospires into the environment throughout their lives [92].
The combination of climate change, low vaccination rate, and urbanization
of rural areas may be increasing the occurrence of leptospirosis in dogs.
Asymptomatic chronic carriers may be shedding leptospires in their urine,
contaminating the environment [125]. In canines, treatment is supportive care,
along with antimicrobial therapy [121]. Penicillin, amoxicillin and doxycycline are
the drugs of choice for treating leptospirosis in dogs.

1.7.2 Clinical Leptospirosis in Felines
Clinical leptospirosis occurs infrequently in cats. One study showed 1/172
(0.5%) urine samples positive by PCR [126]. Additional studies have shown a
range of positivity by MAT from 0%-9.3% [127-131]. However, positive titers for
serovars such as Canicola, Icterohaemorrhagiae, Bataviae, Javanica and
Pomona have been seen clinically in cats throughout the world [6, 29, 126, 127,
132, 133]. Identification of leptospires in cats is mainly from kidney and urine
samples [6, 42]. Seroprevalence in cats has been reported as high as 18% in
the British Isles, Australia 6% and in the US 5% [128, 133]. Shedding of
pathogenic leptospires in feline urine also occurs in feral and wild cats, but the
role in transmission to humans or other animals is unknown [126, 134].
Transmission from other animals have been shown in two separate studies with
the potential transmission of serovar Pomona from dairy cows to a cat [135, 136].
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In one study the cat presented with hematuria, the cat’s urine was both culture
and qPCR positive. The MAT titer was 6400 for both Pomona and Autumnalis.
Exposure to rodents is thought to result in increased titers to either serovars
Copenhageni or Ballum [135]. Therefore, the increased titers to Pomona and
Autumnalis were a result of exposure to domestic animals. Previous work has
also shown cats contract serovars Ballum and Copenhageni when exposed to
rodents [128]. Research indicates that practicing veterinarians should always
consider leptospirosis as a rule-out in cats with renal disease and/or access to
the outdoors [135, 137, 138]. Cats have been shown to shed Leptospira in their
urine but more research is needed to determine shedding frequency and duration
[139]. Interestingly cats can have a negative MAT titer but still be shedding
Leptospira in their urine [128]. Therefore, tests in addition to MAT such as PCR
testing for urinary shedding need to be carried out to determine positivity in cats.
In addition, cats infected by leptospires can present with no clinical signs. [135,
137]. This appears to be a global phenomenon which may also be due to under
reporting of leptospirosis in cats [126, 137-139].

1.7.3 Clinical Leptospirosis in Livestock
1.7.3.1 Ruminants
In 1935, bovine leptospirosis was first reported in Russia [140]. Clinical
signs were decreased milk production and abortions. Reports of bovine
leptospirosis soon followed in Palestine. Two different serotypes had been
identified, in Europe L. bovis and in US, L pomona, both had also caused illness
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in humans. Blood in the milk of dairy cows was frequently seen in mild disease
[140]. In the early 1950s it was believed leptospires shed in urine from infected
animals was crucial to spreading the disease. Research conducted at the time
indicated beef and dairy cattle can shed the bacterium for up to two years [141].
Another study determined cattle can shed Leptospira in their urine for only 70
days [142]. Recovery and shedding of Leptospira in another study was found to
occur for up to 90 days [143]. The first documented case of bovine leptospirosis
in the US was in 1947 by Baker and Little and subsequently identified in 1950 by
Goehenour and Yager [143]. Up to 70% of US bovine herds were seropositive at
this time. The first vaccine was developed in 1953 by Charles York [143]. The
introduction of a bacterin and subsequent vaccine in the 1950s was followed by a
decline in the incidence of bovine leptospirosis [144, 145].
Serovar Hardjo in bovine and sheep can be transmitted directly through
sexual contact, urine exposure, infected placenta or uterine infection and do not
seem to be impacted by levels of rainfall and is difficult to control by routine
management practices [146]. In ruminants, incidental infections occur more
often by indirect transmission by contaminated surfaces, feed and water [146].
Most infections in ruminants tend to be subclinical. However, exceptions to this
occur in the very young presenting with meningitis, renal disease, hematuria,
jaundice, hemoglobinuria and death [146]. Older animals can also present with
these signs, but occurrence is rare. Pregnant or lactating females can present
with agalactia or reproductive damage from either a host-maintained or incidental
leptospiral infection in both bovine and sheep [146].
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Clinical findings in cattle vary with the serovar causing the infection.
Abortion caused by Pomona in cattle will occur 1-6 weeks after acute infection
whereas serovar Hardjo abortion occurs 4-12 weeks after initial signs [146]. A
chronic result of infection by serovar Harjo is infertility, however this can be
controlled by vaccinating the herd [146]. In utero leptospiral infections can cause
abortions, stillbirths, and weak offspring, mostly caused by serovars Pomona or
Hardjo. Abortion is frequently caused by serovar Pomona (up to 50%)
compared to serovar Hardjo (3-10%) [146]. When abortions occur, the fetus and
placenta typically contain a heavy load of leptospires resulting in risk of exposure
to farm workers and veterinarians. Shedding of Leptospira in the urine is
common and can aid in transmission of the disease to other mammals and
humans. Exposure to Leptospira in humans and other mammals can occur after
contact with stock ponds and slow-moving streams contaminated through urinary
shedding of leptospires by cattle. Economic losses due to reproductive failures
on cattle and dairy farms, along with decreased milk production can be high [10].
In dairy cows, quality and production of milk can be affected [147]. Financial loss
due to human illness can also occur due to lost wages and medical costs.
Finally, serovar Hardjo in both bovines and caprines has been shown to persist in
the mammary glands [146].
In sheep, leptospirosis is more common in countries with large ovine
populations, such as New Zealand and Australia. Although infections in other
countries do occur. Leptospiral abortions in sheep and goats generally occur late
in gestation [146]. Abortion is mainly caused by serovar Hardjo, although
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serovars Pomona, Bratislava, Grippotyphosa, Sejroe, Autumnalis and Ballum
have also been implicated [146, 148]. Abortion, infertility, neonatal mortality and
reduced milk production are common in small ruminants [148, 149]. Systemic
infections pyrexia, anemia and hemorrhagic syndromes are seen, but rarely [148,
149]. Sheep are considered carriers of serovar Hardjo [86, 148]. Leptospiral
infections in sheep are still considered rare when compared to bovine and swine,
however the seroprevalence appears to be increasing [148]. Ongoing farm
management is critical in containment of leptospirosis in small ruminant herds
[148]. Isolation of infected animals and timely vaccination are critical. In 2011,
80% of small ruminants were located in developing countries and 70% of these
were residing in tropical environments [148]. Management is critical in these
areas since leptospirosis is more common in tropics [6, 13, 15, 150]. Increased
incidence is seen in the last several weeks of gestation or postpartum in sheep
[146]. Occurrence of leptospirosis in goats ranges from 2.6% in Spain to 31% in
Brazil [149]. Literature regarding leptospirosis in goats is limited compared to
other ruminant species and swine. This could be because losses through
production and diseases in goats are not seen as a significant concern in
developed countries compared to developing countries [86].
Vaccines are available for bovines (worldwide) and small ruminants in
some countries, such as Australia, but not licensed in the US (Appendix One).
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1.7.3.2 Swine
Leptospirosis in swine is common. The first reported isolation of
Leptospira serovar Hardjo in swine was in 1983 [151]. Serovar Hardjo is typically
not isolated from swine, however both serovars Bratislava and Pomona are
common [9]. Seroprevalence is dependent on location. Leptospires are
commonly found in swine all over the world with symptoms ranging from subclinical to abortion [152-154].
Leptospirosis in swine occurs worldwide [86, 155]. Reproductive losses
caused by serovars Canicola, Pomona, Icterohaemorrhagiae, Grippotyphosa,
Bratislava and Tarassovi can cause significant losses through abortion [86]. In
young animals, signs such as jaundice, renal failure, hematuria and hemorrhage
from acute infection occur and can be fatal [86]. Serovar Pomona is a common
cause of infection in young pigs. Leptospirosis has been detected in feral swine
throughout the US, presenting a threat to other animals and humans [155].
Serovar Bratislava was the prominent serovar detected in a nationwide study of
feral swine [155]. In domestic swine serovar Bratislava is the major cause of
reproductive failure in Europe and occurrences in the US are on the increase [86,
156, 157]. The complete genome sequence for serovar Bratislava from a pig
(strain PigK151) was published in 2015. Until then, a complete genome
sequence had only been completed on human Leptospira serovars Lai and
Copenhageni [158]. A vaccine with serovars Bratislava, Canicola,
Grippotyphosa, Pomona, Hardjo and Icterohaemorrhagiae is available
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specifically for breeding swine [159]. A vaccine without serovar Bratislava is also
available [160].
The successful treatment of leptospirosis for cattle, sheep and swine
involves the use of tetracycline, oxytetracycline, amoxicillin and enrofloxacin
[147].

1.7.4 Sea Lions
The occurrence of leptospirosis is not limited to mammals on land. The
first report of leptospirosis in sea lions was in 1970 off the coast of California
[161]. Only adult males (2-8 years old) were involved with an overall mortality of
40%. An outbreak occurred the same year off the coast of Oregon, with 2%
mortality [161]. MAT titers from sea lions beached in California in 1971, showed
high titers to Pomona (100,000) and cross-reaction to Autumnalis (10,000).
Since 1971, numerous outbreaks have occurred in both sea lions and otters [8,
162-164]. An outbreak in 2004 along the coast from southern California to
Washington showed high prevalence of serovar Pomona [163]. A high morbidity
(65%) and mortality rate (73%) in the California coast sea lions was detected. A
majority of those infected were juveniles (71%) and 92% of infections were in
males [163]. The 2004 outbreak occurred throughout the year, with the highest
number of cases between July-December. Surveillance of the California
coastline continued through 2007. No outbreaks occurred between 2005-2006,
however another outbreak happened in 2007 [163]. Morbidity and mortality were
63% and 74% respectively, and 58% were juveniles [8, 163]. Outbreaks in sea
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lions off the coast of California have been on the increase with the second largest
outbreak occurring in 2018, over 200 were diagnosed with 70% mortality [165].
Clinical signs of illness in the sea lions include fever, emaciation,
polydipsia, reluctance to use hind flippers, and dehydration [161, 163, 166]. High
mortality occurs every 3-5 years as they migrate along the Pacific coast [8, 166].
Leptospirosis in sea lions appears to be endemic with cyclic outbreaks caused by
asymptomatic carriers shedding leptospires and exposing younger animals for
long periods of time [166]. Asymptomatic carriers are more common among
older adults and have been shown to shed leptospires post-infection for up to
154 days [8]. The cyclic nature of outbreaks is believed to be due to the
interaction of birth rates and herd immunity. Where young animals are infected
during outbreaks, many become carriers that spread leptospires to incoming
young adults for years, and spread with the migration of males to Alaska and
back [8]. In addition, there is possible involvement of other animals contributing
to the infection in sea lions [163]. The difference in males vs females is likely
due to yearly migration north of males, while females and pups stay by the
rookeries in Southern California [163, 164]. This also poses a risk of
transmission to humans and other animals coming in contact with sea lions.

1.8 History of Leptospirosis in Horses
The first experimentally induced leptospirosis in horses occurred in 1930
after exposure to Leptospira icterohaemorrhagiae [167]. In 1948, the first
evidence of antibodies to Leptospira in horses (22/291, 7.5%) was reported [168,
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169]. The first recorded isolation of Leptospira pomona by aerobic culture in
horses in the United States (US) was achieved in 1952 [170]. In 1953 a horse
was diagnosed with leptospirosis after becoming ill, with no other animals on the
farm sick nor had increased titers [171]. The source of the Leptospira was never
found. Prior to 1952, the horse had not yet been considered to be susceptible to
leptospirosis, and thus any possible systemic infections were never diagnosed.
In addition, abortions in the horse caused by Leptospira were also not well
defined.
Prior to 1950, leptospirosis in horses was associated with uveitis, not
clinical presentations. In 1950s the only evidence linking recurrent uveitis to
leptospirosis, was increased titers [172].
Since then, global studies have revealed increased seroprevalence of
leptospires in the horse, including the US. The presence of specific serovars
varied depending on the location/country and percent positivity. A study in New
York showed 30% of horses tested were seropositive to L. pomona,
icterohemorrhagieae, or Canicola [173]. Whereas a study in Illinois showed
prevalence to serovars Pomona, Canicola and Grippotyphosa (19.5%, 9.5% and
2.5% respectively) [174]. In 1957 several case studies of leptospirosis were
reported in California. Several mares aborted, and serological agglutination was
to Leptospira Pomona, the organism was never isolated [175].
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1.8.1 Equine Leptospirosis
Horses are thought of as incidental hosts for most serovars of
leptospirosis, except for L. interrogans serovar (sv) Bratislava [121]. L.
interrogans (sv) Bratislava, has caused abortions in horses, especially in Ireland
[86, 176, 177].

A 1998 serological study in New York revealed a high

prevalence of both L. interrogans (sv) Autumnalis and L. interrogans (sv)
Bratislava, with a smaller percent of five other serovars occurring in the equine
population throughout the state [178, 179]. Serovar Bratislava was first isolated
from a hedgehog in 1953. The hedgehog is considered the maintenance host for
this serovar in Europe [180]. In swine, Bratislava causes abortion and neonatal
death [181]. Swine are considered a maintenance host for this serovar in both
Europe and the US. Dogs are also a maintenance host for serovar Bratislava, as
both clinical illness and abortion have been seen in that species [86]. Domestic
and wild dogs may pose a risk for horse exposure [182]. Exposure and
seroprevalence for Bratislava in humans has also occurred [183].
Since the 1980s, horses in Europe have been considered maintenance
hosts for serovar Bratislava, although clinical infections have occurred
[177, 184]. However, the association of Bratislava with disease in horses is still
not conclusive [86, 87, 157, 185, 186]. Serovar Bratislava has never been
isolated aerobic culture from horses in the US due to the fastidious nature of this
organism [9]. There is evidence that the strains detected by multiple-locus
variable-number tandem repeat analysis (MLVA) testing and sequencing among
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animals, are not the same (pigs, horses, cattle, sheep, dogs, hedgehogs and sea
lions) [157, 187, 188].
Transmission of serovar Bratislava in mammals can occur through
exposure to infected urine, placenta, wildlife and possibly via breeding [9, 185,
186]. The differences in clinical syndromes caused by serovar Bratislava in
Europe and North America could be affected by equine genetics, strain
differences and/or environment. Clinically, Bratislava cases in Europe included
abortion, equine recurrent uveitis (ERU), jaundice, fatigue and respiratory
distress. However, clinical cases related to serovar Bratislava have not been
recognized in North America [177, 185]. Horses are genetically homogeneous.
Thoroughbreds from Europe and North America do not cluster together due to
differences in stallions used for breeding as seen in Figure 3.1 [189, 190]. Slight
genetic diversity may contribute to differences seen between Europe and North
America pertaining to serovar Bratislava. Environmental pressure to strains of
serovar Bratislava may also contribute to these differences. Strains of serovar
Bratislava circulating in Ireland and the European continent also differ [187]. In
Europe, serovar Bratislava is considered both a non-pathogenic resident and a
pathogen in the horse. In the US it is only considered a non-pathogenic resident
or commensal organism. Further research is needed to better understand the
pathogenesis of these strains.
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Figure 1.5: Principal Component Plot of Global Genetic
Relatedness in Thoroughbred Horses*

*McGivney et al 2020
In North America, transmission of Leptospira to horses is believed to be
mainly through contact with wildlife; however, contact with contaminated feed,
water and/or soil infected with Leptospira does occur. Skunks are thought to be
the maintenance host for serovar Kennewicki, Hardjo is maintained by cattle, and
Grippotyphosa by raccoons [176]. Additional transmission may occur through
semen and mare’s milk. Male horses could be involved in the spread of
leptospirosis. Both swine and cattle have been shown to pass Leptospira
through their semen [191, 192]. Stallions have also been shown to harbor
leptospiral DNA [186, 193, 194]. Leptospira have been detected in the milk of
female mammals during lactation in rats, bovine and humans [104, 195, 196].
Thus, another potential point of transmission could be through the mares’ milk,
though to date there has been no published reports of such transmission.
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In horses, leptospirosis has several clinical syndromes. In pregnant
mares, abortion, stillbirth or premature foaling is common. In yearlings recurrent
uveitis (Moon Blindness) and renal failure are frequent [197]. Other rare
systemic clinical manifestations seen in horses are fever, anorexia, lethargy,
respiratory distress, encephalitis, jaundice and liver failure. Several studies have
reported increases in the seroprevalence within the past twenty years in horses
[185, 198-200]. In Sweden, a study looking at 2000 horses over a period of a
year found a substantial number were positive for both L. interrogans serovars
Bratislava and Icterohaemorrhagiae using MAT (16.6% and 8.3% respectively), a
majority of titers occurred at 1:100 [185]. A study from Brazil also showed a high
seroprevalence of Icterohaemorrhagiae along with L. interrogans (sv) Castellonis
and L. interrogans (sv) Djasiman [201]. Both, the Swedish and Brazilian studies
demonstrated higher titers in older animals vs. yearlings. This has also been
observed in other studies [200, 202]. A study conducted in 2011 by Carter et al
showed seroprevalence in horses throughout the United States and one
Canadian Province with a range from 10% to 30% depending on the region [203].
These studies also showed a high percent of animals with low titers to numerous
serovars, which indicates exposure, but not necessarily disease. MAT cross
reactivity is common and is caused by the persistence of IgM and IgG antibodies
[15, 37]. Persistent titers can remain for years after infection and/or additional
exposure without presence of infection. Unless blood titers are checked
repeatedly throughout the year, the chance of detecting a highly significant titer
could be elusive. A survey of veterinary diagnostic laboratories in the United
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States was conducted to determine the number of cases, serovars and abortions
seen in both horses and cattle [204]. Test results indicated a much higher
detection rate in cattle compared to horses except for one laboratory. In horses,
penicillin plus dihydrostreptomycin has been used effectively to treat leptospirosis
[176].

1.8.2 Equine Recurrent Uveitis
Chronic uveitis (aka moon blindness or equine recurrent uveitis) caused
by leptospires is a common problem and is one of the leading causes of
blindness in horses [2, 185, 198, 202, 205]. Uveitis is inflammation of the
vascular tissue in the eye, specifically the iris, ciliary body (anterior uvea) and
choroid (posterior uvea) [112, 206, 207]. These are part of the uveal tract (Figure
1.6). Between the peripheral vasculature and the inner structure of the eye,
there are two barriers (blood/aqueous and blood/retinal barriers) to prevent cells
and larger molecules from entering the eye. The blood/aqueous barrier consists
of the iris and ciliary body barrier and blood/retinal barrier comprises the choroid
[112]. The barriers allow the eye to be immune privileged (limiting an immune
response), until one or both of those barriers are disrupted. Disruption of one or
both barriers allow leakage through the vasculature causing an immune
response, leading to uveitis. The eye is also protected from an immune
response through decreased antigen presenting cells and a lack of lymphatics
[112]. Without these protections, a mounted immune response could lead to

39

irreversible damage. The theory that ERU is caused by an immune mediated
response, first appeared in the literature in the 1980s [208-210].
Uveitis can be caused by trauma, infection (either local or systemic),
neoplasia or can be idiopathic [206, 211]. Uveitis can either be acute with
sudden onset, chronic (never healed) or recurrent, which is referred to as ERU.
Figure 1.6: Anatomy of the Equine Eye

[212]
There are three forms of ERU. The first form comprises an intraocular
inflammatory process which reoccurs months after the initial diagnosis of uveitis,
and with each occurrence becomes more severe [112, 206]. This is considered
the classic form of ERU. The second form of ERU is called insidious and is
typically seen in Appaloosas horses [206]. This includes a low-grade
inflammatory process which persists with no outward signs, although damage to
the eye continues. The third type is posterior and is seen more in Warmblood
horses. Inflammation is mainly in the vitreous, retina and choroid [211]. ERU is
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more common in the US (2-25%), and some European countries (8-10%) in the
general equine population. However, occurrence in Britain (0.3%) is much lower
when compared to other countries [2, 206, 213]. Reasons for discrepancies
could be due to the type of breeds and/or genetics of the horses in Britain
compared to other countries. Environmental factors may also contribute to the
differences. Numerous studies have shown a predilection of ERU to occur more
frequently in Appaloosas and Warmblood horses compared to other breeds [2,
214, 215]. In both Appaloosas and German Warmblood horses, genetic risk
factors have shown to contribute to a higher percent of ERU. Additionally, these
two breeds show an association with the MHC-I haplotype ELA-A9 and ERU
suggesting a genetic component [216-218].
The contributing causal factors of ERU are elusive. However, in the midtwentieth century a correlation between ERU and leptospirosis was proposed.
There was no concrete evidence showing a relationship between the two and
why, until recently [172, 219].
The suspicion that ERU was related to Leptospira was first suggested in
the 1940s and later substantiated in the 1950s [169, 170, 220]. In one study,
horses with recurrent iridocyclitis (ERU) had 85% (223/263) agglutinating
antibodies to Leptospira. Initial reports indicated L. pomona as the principal
cause of both leptospirosis and ERU. However, serovars Canicola and
Icterohaemorrhagiae have also been associated with both leptospiral infections
and uveitis [173].
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Currently, leptospirosis is considered the primary bacterial infection
leading to ERU [112, 221]. Uveitis can occur early after a few months or years
after leptospiral infection [220, 222, 223]. Serovar Pomona is still considered the
most common cause of ERU. Serovars Grippotyphosa and Bratislava have
recently been implicated [224, 225].
In 1985 antigenic correlations between the cornea and Leptospira were
discovered [210]. In 2005, two novel lipoproteins were localized in pathogenic
Leptospira interrogans, but not in saprophytic Leptospira. Both reacted with the
ocular components of horses, signifying a role in equine uveitis [205]. These two
lipoproteins, referred to as leptospiral recurrent uveitis associated proteins A and
B (LruA and LruB) were identified in the inner membrane of only pathogenic
Leptospira. Increased levels of both IgA and IgG to both LruA and LruB were
detected in fluid from horses with uveitis but not in normal eyes (controls) [205].
Furthering the belief that uveitis was triggered by an immune response, the study
showed an antisera specific reaction by ocular components to both LruA and
LruB. Both LruA and LruB have also been found in humans with leptospiral
induced uveitis [213, 226]. A study published in 2010 also demonstrated the
relationship of Leptospira to ERU [224]. An additional novel protein was also
discovered, leptospiral recurrent uveitis associated protein (LruC) and published
in 2012. LruC is also considered to be associated with ERU [227].
Vimentin, a-crystallin B and b-crystallin B2 have been shown to be critical
for preserving lens clarity. LruA was found to be associated with both vimentin
and a-crystallin B when they cross-reacted with LruA antiserum [224]. LruB
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antiserum was found to cross-react with b-crystallin B2. In one study, eye fluid
was collected from ERU eyes which contained significantly higher levels of
antibodies recognizing vimentin, a-crystallin B and b-crystallin B2, when
compared to controls [224]. This study further demonstrates the immune
relevant reactions occurring following a leptospiral infection and subsequent
ERU.
For a localized antibody reaction in the eye to Leptospira to be conclusive,
there has to be 4x the MAT titer in the eye compared to MAT serum titers. This
is referred to as the Goldmann-Whitmer coefficient (C-value) [228]. A titer 4x
higher in the eye fluid, implicates a leptospiral induced uveitis has occurred.
Blindness may not occur for months or even years after infection with
leptospirosis. Treatment with either doxycycline or tetracycline for one month
may minimize uveitis but rarely will prevent the progression to blindness [229].
In Kentucky, the occurrence of leptospirosis in horses has been well
documented, especially in the past several decades, with over 25 articles
compared to less than 20 in the remainder of the US during the same timeframe.
The most common serovar found in Kentucky is Kennewicki (serogroup
Pomona), however the occurrence of several other serovars is not uncommon
[87, 230]. Interestingly, for the first time in 30 years, the University of Kentucky
Veterinary Diagnostic Laboratory 2019-2020 did not diagnose any leptospiral
abortions in horses. The first vaccine licensed for horses
(https://www.zoetisus.com/products/horses/lepto-eq-innovator/index.aspx) which
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came on the market in 2015 may have had a role in the decline of cases,
especially in the Central Kentucky Bluegrass region.
Prevention of leptospirosis is multi-faceted. Prevention in animals
includes wildlife control, avoiding feed contamination, clean water, vaccination,
isolation of sick animals and proper farm management practices. In humans,
early identification and monitoring of outbreaks and occurrences, hygienic
practices in the workplace, avoidance of wading or swimming in water
contaminated by animal urine will also help decrease the occurrence of
leptospirosis. Improved awareness by physicians of the symptoms and risks
especially in high-risk areas assist in diagnosis and prevention. Combined, all
can help facilitate the prevention of leptospirosis.
The studies designed for this dissertation were to answer several different
questions pertaining to equine leptospirosis. To address the first question in
Chapter Two, testing methods offered by laboratories of the American
Association of Veterinary Laboratory Diagnosticians for leptospirosis were
examined. A survey was designed to understand if there is enough testing
capacity offered and the types of testing offered by veterinary diagnostic
laboratories in the United States for leptospirosis. In Chapter Three the
seroprevalence of leptospirosis in Central Kentucky was investigated in the
general equine population submitted for necropsy regardless of reason for
submission. The aim of this study was to determine the percent positivity in
kidneys, vitreous humor and urine by real-time PCR; seroprevalence of serovars
Pomona, Grippotyphosa and Bratislava; and the effect of age and gender on
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seropositivity. Chapter Four investigated the effects of pregnancy and/or
infection on the levels of heme oxygenase-1 (HO-1) in serum of horses. The
aims of the study were to determine if pregnancy and/or infection (specifically
leptospirosis) upregulates HO-1 in the same manner seen in other mammals,
and if HO-1 is affected more by pregnancy compared to infection.
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Chapter Two
Survey of Leptospiral Testing Capabilities in the US by Veterinary
Diagnostic Laboratories

2.1 Introduction
The Centers for Disease Control and Prevention defines a zoonosis as a
disease spread between animals and people. Table 2.1 illustrates some recent
outbreaks of zoonotic diseases in the world. One of the most notable zoonotic
disease pandemics in history, COVID-19, is occurring at the time of this writing
and was declared a global health emergency in January 2020 by the World
Health Organization (WHO). Caused by Severe Acute Respiratory Syndrome
coronavirus 2 (SARS-CoV-2), this agent has led to a global public health crisis,
causing high morbidity and mortality in humans. At least 6 of 10 infectious
diseases in humans originate in animals and 3 out of 4 emerging diseases are
zoonotic [61, 231]. As a result, zoonotic disease prevention and management is
one of the highest priorities of public agencies throughout the globe.
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Table 2.1: Zoonotic Outbreaks*
Disease
Vector
Fruit Bat;
Ebola
nonhuman
primate
Mammals
Salmonella
Turtles
Primates to
Yellow Fever
mosquitoes to
humans
Mastomys
Lassa Fever
rodents
H1N1 (swine flu)
Swine

Year
1976;
2014-2016;
ongoing
2006present
1647 (1st
outbreak)
2000-2020

Country

Vaccine

Africa

Trials

Global

No

Africa and
South
America

Yes

1969

Africa

Yes

2009

Global
China, Japan,
Hong Kong,
Taiwan,
Canada
United
Kingdom,
Ireland,
Austria,
Turkey,
Middle East
(Saudi
Arabia,
Qatar, UAE,
Oman,
Bahrain)

No

Worldwide

Yes

SARS

Possibly bats
and/or civet
cats

2003-2004
2020 to
present

MERS-CoV

Dromedary
camels

2012-2019

SARS CoV-2

Unknown
Bats?

2019 to
present

*[232]

No

No

A One Health approach, with full integration of animal health, human
health, and the environment is needed to aid in the prevention of future
outbreaks and pandemics and the related economic losses. In the case of food
production animals, a One Health approach aids in the production of a
wholesome and plentiful food supply and reduces economic losses related to
morbidity and mortality [233]. Optimal animal health is realized through effective
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vaccination programs for diseases such as brucellosis, leptospirosis, rabies and
many other diseases. Vaccination affords protection against leptospiral
infections. However, because of serovar diversity worldwide, a vaccine to
protect against all pathogenic serovars in all species is currently not feasible.
The large number of pathogenic Leptospira serovars (over 300) throughout the
world, along with vaccine development and side effects, are reasons for the
implausibility of one vaccine for a single species.
Good communication and coordination among human health, animal
health, and environmental health professionals’ disciplines can help prevent
future outbreaks of serious diseases. For example, a 2005 Q-fever outbreak in
the Netherlands could have been largely avoided through better communication,
decreasing economic losses and human illnesses [233]. Partnerships formed by
members of the allied health professions have enabled strong surveillance for
West Nile Virus, saving human and animal lives and conserving precious funds
[233]. It is hoped that the One Health philosophy will continue to grow and thrive
to serve public health, animal health, and environmental health.
In the US prior to the 1990s, leptospirosis was sporadic in animals.
However, in the past 30 years, the incidence of clinical leptospirosis has risen,
especially in dogs [88, 122, 234, 235]. Since the 1950s, many peer-reviewed
scientific articles have reported leptospiral seroprevalence in equine and bovine
populations [30, 140, 170, 199, 200, 203].
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There is a wide range of seroprevalence in horses based on location of
premises. A 2009 study conducted in Brazil showed a low seropositivity (8%)
from 1200 equine serum samples [236]. A study in 2013-2014 conducted in
Ethiopia found that the location and age of cart horses made a difference in
seroprevalence [237]. Ethiopia has the largest equine population in Africa,
estimated at 1.91 million and an even larger donkey population (6.75 million)
[237]. Depending on the region in Ethiopia, 184/418 seropositive horses (titers≥
100) ranged from 39.8% to 62.1%. In Europe, the seroprevalence has a broad
range, from 1.5% in Italy to 72.2% in Ireland [238]. Another study published in

2016 found a seroprevalence of over 29% of 747 serum samples from horses in
Italy [239]. A study in Ireland found overall seroprevalence of 72.2% in horses
with serovar Bratislava the highest (59.1%) [177]. A complete list of serovars
detected in the above studies is listed in Table 2.2. The differences in
seroprevalence among these studies could be due to location of the horses not
only between countries, but also within a country and sample size. This also
may be true for the differences in the US. A study published in 2012 showed the
highest seroprevalence in the Western and Southeastern sections of the US to
serovar Bratislava [203]. Two recent studies showed increased seroprevalence
to serogroups Australis and Grippotyphosa in Kansas and serovars Bratislava
and Canicola in Colorado [199, 200].
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Table 2.2 Equine Leptospira Seroprevalence in Different Countries*
Seroprevalence
Year of
Serovars
Paper
Country Species
range of Leptospira
Study
Detected*
spp.
Siqueira
2009Brazil
Equine
C, B, H, P, 2.1% (Autumnaliset al; 2019 2010
He, Pa, V, serogroup) to 53.6%
Ca,
(Bratislava-serovar)
A, J, W,
Py,
Br
Tsegay et
al; 2016

20132014

Ethiopia

Equine

Tagliabue
et al; 2016

20102011

Italy

Equine

Br, D, To,
Pom, M,
G, Ar, Bu,
K, Ca, Cy,
J,
B, Z, He,
H, Au Ce
I,
Sz, Pa, R,
Sh,
Ta
Br, C, I,
Gr

0.2% (Hebdomadisserovar) to 34.5%
(Bratislava-serovar)

2.9%
(Grippotyphosaserovar) to 78.5%
(Bratislava-serovar)
Ellis et al; 1979Ireland
Equine
Br, H, C,
1.7% (Canicola1983
1980
Py, Ba,
serovar) to 59.1
Ca
(Bratislava-serovar)
* A=Autumnalis; Au=Australis; Ar=Arboreae; B=Bataviae; Br=Bratislava;
Bu=Bulgarica; Ca=Canicola; Ce=Celledoni; C=Copenhageni; Cy=Cynopteri;
D=Djasiman; G=Grippotyphosa; H=Hardjobovis; He=Hebdomadis;
I=Icterohaemorrhagiae; J=Javanica; K=Kremastos; M-Medanensis; Pa=Pana;
P=Pomona; Py=Pyrogenes; R=Robinsoni; Sh=Shermani; Sz=Szwajizak;
Ta=Tarassovi; To=Topaz; V= Valbuzzi; Z=Zanon
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In many areas of the world, testing for Leptospira is not performed,
negating surveillance in areas where leptospirosis may be emerging and/or
prevalent. Diagnostic monitoring for the presence of leptospirosis in animals is
critical to limit the spread of the diseases to both animals and humans. The aim
of the survey done for this dissertation was to assess the availability of
leptospirosis testing offered by member laboratories of the American Association
of Veterinary Laboratory Diagnosticians (AAVLD), the extent they are utilized,
and to better understand if there is enough testing capacity offered by these
laboratories.

2.2 Materials and Methods

2.2.1 Survey
A survey was sent to 60 AAVLD laboratory directors in early October
2015. The survey requested the laboratories to report all the leptospirosis test
methods offered (e.g., MAT, PCR, FA), serovars measured, and the average
number of both equine and bovine cases per year (e.g., abortions, uveitis,
chronic renal or systemic leptospirosis) (Appendix 3).

2.2.2 Statistics
Descriptive statistics (sample size, averages, percent) and graphs were
determined using Microsoft Office Excel 2016 for MAC.
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2.3 Results
Seventeen of the 60 AAVLD/NAHLN laboratories (28%) responded to the
survey. Only 13/17 (76.5%) of responding laboratories offered one or more tests
for leptospirosis. One laboratory had discontinued testing in the past year due to
lack of submissions and interest. Table 2.3 includes the laboratories and
serovars offered by the responding laboratories in the study. A current listing
and map of all AAVLD accredited laboratories and leptospiral tests available are
in Appendix 4 and 5 respectively. Table 2.4 includes the number of laboratories
testing for the following serovars by MAT: Pomona, Hardjo,
Icterohaemorrhagiae, Grippotyphosa, Canicola, Bratislava, Autumnalis, Sejroe
and Copenhageni. Responses from the 17 laboratories indicate 76.5% are
testing for similar serovars. The serovars commonly analyzed by MAT were
Pomona, Hardjo, Icterohaemorrhagiae, Grippotyphosa, Canicola, and Bratislava.
Serovar Bratislava was tested in 10/13 laboratories (76.9%). One laboratory
tested for Bratislava specifically in bovine samples only.
To determine whether Leptospira was the cause of an abortion in either
horses or cattle, 10/17 (58.8%) utilized PCR while 4/17 (23.5%) ran FA tests.
Regarding the diagnosis of Equine Recurrent Uveitis, 7/17 (41.2%) used PCR
and/or MAT for analysis. Ten of the seventeen respondents (58.8%) do not test
eye fluid for the presence of leptospires.
A total of 10,376 bovine samples from 13 laboratories were submitted for
Leptospira MAT testing. The range of bovine cases submitted for testing was 103774/year (Table 2.5 and Figure 2.1). A total of 4415 equine samples were
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tested, the lowest in one state was 1/year and highest was 2731/year. The
average number of abortions caused by Leptospira in bovine was 2.4/year and in
equine 1/year (Figure 2.2).
Table 2.3: MAT Serovars Offered by Responding Laboratories
Laboratory MAT Serovars Offered-Equine and/or Bovine
Pomona, Hardjo, Icterohaemorrhagiae, Grippotyphosa,
1
Canicola, Autumnalis, Bratislava
Icterohaemorrhagiae, Hardjo, Pomona, Grippotyphosa,
2
Canicola, Bratislava
Pomona, Icterohaemorrhagiae, Canicola, Grippotyphosa,
3
Hardjoprajitno, Bratislava, Sejroe
Bratislava, Canicola, Grippotyphosa, Hardjo,
4
Icterohaemorrhagiae, Pomona
Canicola, Grippotyphosa, Hardjo, Icterohaemorrhagiae,
5
Pomona, Bratislava
Bratislava, Canicola, Pomona, Grippotyphosa,
6
Icterohaemorrhagiae, Hardjo
Autumnalis, Bratislava, Canicola, Grippotyphosa,
7
Icterohaemorrhagiae, Hardjo, Pomona
8
Not Offered
Bratislava, Canicola, Grippotyphosa, Hardjo, Copenhageni,
9
Pomona
Canicola, Grippotyphosa, Hardjo, Icterohaemorrhagiae,
10
Pomona
Grippotyphosa, Hardjo, Icterohaemorrhagiae, Pomona, Sejroe
11
(Canicola and Bratislava also included for Bovine panel)
Bratislava, Canicola, Grippotyphosa, Hardjo,
12
Icterohaemorrhagiae, Pomona
Canicola, Autumnalis, Bratislava, Hardjo,
13
Icterohaemorrhagiae, Pomona, Grippotyphosa
14
Not Offered
15
Not Offered
16
Discontinued
Grippotyphosa, Pomona, Hardjo, Icterohaemorrhagiae,
17
Canicola
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Table 2.4: Laboratory Analysis of Serovars by MAT*
Serovar
Number of Laboratories Testing
Pomona
13/17 (76.5%)
Hardjo
13/17 (76.5%)
Icterohaemorrhagiae
13/17 (76.5%)
Grippotyphosa
13/17 (76.5%)
Canicola
13/17 (76.5%)
Bratislava
13/17 (76.5%)
Autumnalis
3/17 (17.7%)
Sejroe
2/17 (11.8%)
Copenhageni
1/17 (5.9%)
*Microagglutination Test
PCR targeting pathogenic Leptospira was the principal test used to
determine leptospiral abortions. Of those labs responding to the survey, 25% of
laboratories do not test for leptospirosis and 62% did not test eye fluid by PCR.
Table 2.5: Total Number of Samples-Average Bovine and Equine
(2014/2015)
Laboratory
MAT
Total
Bovine
Equine
(previous
Diagnostic
Samples/year Samples/year Samples/year
number)
Test
1
Yes
4259
3211
1048
2
Yes
1346
1165
181
3
Yes
3992
3774
218
4
Yes
271
235
36
5
Yes
160
150
10
6
Yes
260
250
10
7
Yes
110
92
18
8
Yes
24
10
14
9
Yes
583
505
78
10
11
12
13 (17)
14 (8)
15 (14)
16 (15)
17 (16)

Yes
Yes
Yes
Yes
No
No
No
Discontinued

123
689
85
2889

76
688
62
158
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47
1
23
2731

Figure 2.1: Average MAT Bovine and Equine Leptospiral Submissions
(2014/2015)
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Figure 2.2: Average Bovine and Equine Leptospiral Abortions (2014/2015)
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2.4 Discussion
Only 28% of AAVLD accredited laboratories responded to the survey. The
low number of respondents makes it difficult to determine the extent of leptospiral
testing throughout the US. A high percent of the responding laboratories tested
for serovar Bratislava. Previous US studies have shown a high local
seroprevalence for serovar Bratislava in horses [199, 203]. One study showed a
seroprevalence of 30.5% for titers≥100 where another study showed 31.6% with
titers≥ 200 to serovar Bratislava [199, 203]. A high seroprevalence does not
56

necessarily translate to either clinical disease or abortion in horses, Bratislava is
rarely reported as a pathogenic serovar [86]. However, it has been identified by
MAT in horses with clinical infections and MAT and culture in aborted fetuses
[86, 184]. Bovine seroprevalence of serovar Bratislava is infrequently reported
and ranges from <1% to ~23% [240-243]. There are few reports in the US of
seroprevalence to Bratislava in cattle [243, 244]. However, abortions in
seropositive bovines in Spain and Brazil have occurred [240, 242, 245]. A 1997
study in Spain found 25.4% of cattle tested had a seroprevalence to Bratislava,
with 9.7% aborting from 32 farms [240]. The study in Brazil found 15.74%
seroprevalence to Bratislava in cattle from 15 farms [242].
Four of the laboratories responding to the survey did not offer leptospirosis
testing. Presently, three laboratories are now offering MAT and PCR testing.
The decision to begin offering leptospirosis testing at a veterinary diagnostic
laboratory may be driven by evidence of increased leptospiral prevalence in the
US and across the globe. From January 2014 through October 2020, there were
114 ProMed-mail reports of leptospirosis, 50 of which were animal outbreaks
(https://promedmail.org/promed-posts/). During this same timeframe, 20 reports
of leptospirosis outbreaks in animals occurred in the US. Between January
2010-January 2015 there were only 6 reports in ProMed-mail of leptospirosis in
animals in the US while the number of reports in the world increased by 33.3%
and in the US 70%. There appears to be an increase in reporting of animal
leptospirosis in the United States and globally. However, this may not represent
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an increase in the incidence of clinical human or animal leptospirosis
geographically.
A high percent (77%) of laboratories that responded to the survey offer
testing for Leptospira by PCR. A small percent of laboratories tested eye fluid for
Leptospira, therefore many cases of Equine Recurrent Uveitis may remain
undiagnosed. Most diagnostic testing for uveitis is likely done pre-mortem at
veterinary clinics and hospitals, rather than on postmortem examinations
(personal communication-Dr. Craig Carter, UKVDL).
Samples submitted to veterinary diagnostic laboratories are not random
and do not reflect a true incidence of a disease confirmed in specimens sent from
the field. Practicing veterinarians submit specimens to veterinary diagnostic
laboratories and request testing for leptospirosis because of clinical suspicion as
a possible cause of morbidity or morbidity in an animal or group of animals.
Furthermore, the risk of exposure to Leptospira by veterinarians and animal
owners may not be considered and may be overlooked. Considering the low
numbers of leptospiral testing in Figures 4 and 5, it appears laboratories that do
offer testing services for leptospirosis are being underutilized. In addition,
veterinarians and animal owners may decide not to request a necropsy on
animals dying on the farm for economic reasons or lack of curiosity.
There are 60 AAVLD laboratories in various states throughout the nation,
with some states operating multiple laboratories). Every state except Idaho,
Nevada, Alaska, Rhode Island, Massachusetts and Maine have an AAVLD
laboratory. Two states refer leptospiral testing out of state. Seven states (14%)
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do not run MAT titer. Since 12% of the states do not test for leptospirosis there is
a likelihood that some clinical cases are not detected. Current information
reported from ProMED-mail and journal articles, indicates cases of leptospirosis
have increased over the past ten years in both humans and animals [73, 150,
246].
It is currently accepted that climate change can increase the risk of future
pandemics [63, 64]. Climate change has a role in emerging a re-emerging
zoonotic pathogens which can lead to high morbidity and mortality in both
animals and humans. This is also true for leptospirosis as new serovars are
emerging and infections with increased incidence in both animals and humans
[234, 246]. There is a critical need for more veterinary diagnostic laboratories to
offer high quality and timely testing for leptospirosis throughout the US. When
animals present with clinical signs of leptospirosis, it is important that the disease
be ruled-in or ruled-out in a laboratory, with follow-up to be sure that humans
exposed to the animal(s) are not also infected. A follow-up study is
recommended to confirm the total availability of leptospirosis testing in the US,
including commercial laboratories, to assure the timely and accurate identification
of Leptospira-related disease in both animals and humans.
This study and other recent studies suggest a lack of reporting positive
titers and/or diagnoses for clinical leptospirosis around the US. This is likely due
to lack of awareness of those laboratories that offer testing or the lack of
availability of high-quality testing offered by diagnostic laboratories. This can
also be explained by lack of clinical suspicion of leptospirosis by producers,

59

practicing veterinarians, and diagnostic laboratory staff [29, 199, 244, 247].
Finally, both veterinary and human laboratories should work closely to aggregate
data on confirmed cases of leptospirosis to provide much needed medical
situational awareness of this widespread disease which can cause severe illness
and can be fatal [248]. To be sure, increased testing and diagnosis of
leptospirosis in clinical veterinary medicine would likely translate to improved
animal health, public health, in the spirit of One Health.

60

Chapter Three

Assessment of the Carrier State of Leptospira in 500 Juvenile and Adult
Horses in the Bluegrass Region of Kentucky
3.1 Introduction
Leptospirosis has been identified on every continent except Antarctica
[14]. Leptospirosis can affect mammals, insects and birds [6, 26]. Leptospirosis
in livestock is common and can be linked to leptospirosis in horses. Horses
grazing pastures once occupied by livestock can pose a risk of exposure to
Leptospira. Serovar Hardjo is the primary serovar in both bovine and ovine in the
US but has rarely been a problem in horses. However, transmission of other
serovars such as Bratislava can occur [249-251].
In Central Kentucky seroprevalence of Bratislava has been detected
since the early 1990s [252, 253]. Serovars Bratislava and Grippotyphosa have
been shown to cause abortion, but serogroup Pomona serovar Kennewicki is
currently the predominant agent causing abortion in Kentucky [87, 253]. In
Kentucky, serovar Bratislava is not included in the panels that are routinely
requested by clients at the University of Kentucky Veterinary Diagnostic
Laboratory (UKVDL) (personal communication-Dr. Craig Carter, UKVDL).
One of the objectives of this study was to determine the seroprevalence of
Bratislava in the general equine population. Leptospirosis serology testing in
Central Kentucky is run mainly on pregnant mares to monitor titer levels in their
herds. In Central Kentucky many farms begin MAT surveillance in October,

61

every two to four weeks through March until all mares foal (personal
communication-Dr. Craig Carter, UKVDL). Many equine veterinarians practicing
in the Bluegrass Region of Kentucky use these titers to decide whether to
provide prophylactic antibiotic treatment for mares to prevent abortion (personal
communication-Dr. Stuart Brown, formerly of Hagyard Equine Medical Institute).
Unless non-pregnant or male horses are sick, monitoring MAT titers are not
routinely done. Therefore, it is essential to determine the prevalence of serovar
Bratislava to help to understand the role is may play regarding clinical disease in
horses. Because of the widespread seroprevalence of serovar Bratislava, it is
important to determine the risk of exposure and potential of illness in mammals,
including humans.
More than 90 peer-reviewed articles have been published in the scientific
literature over the past 10 years investigating leptospiral seroprevalence in
horses. To date there have been no studies published evaluating the
postmortem Leptospira carrier state in horses. Previous papers have focused on
necropsy studies in aborted fetuses but not in juvenile and/or adult horses.
Papers published in the past 40 years studying the causes of abortion vary
depending on the locale. Over 45 of the previous studies were undertaken in
Kentucky and the British Isles. Donahue et al (1991) published the first extensive
article on equine leptospirosis in Kentucky from a diagnostic laboratory
perspective [252]. The study found 15/584 (2.5%) equine abortions/stillbirths
over a one-year period were due to leptospirosis. A paper in 1993 investigated
two foaling seasons (1988 and 1989) in Kentucky [254]. Over 1200 aborted
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fetuses, placentas and stillborn foals were examined to determine the etiology
ranging from infectious disease, twinning and/or dystocia. More than 40% were
aborted after 300 days. Abortions in mares with placentitis occurred on average,
at day 276 [254]. Out of the number of abortions due to placentitis, 37 of 236
(15.67%) were caused specifically by Leptospira [255]. This was the first
evidence of Leptospira spp. causing an increased number of abortions in
Kentucky. Another study examined fetuses, stillborn foals and placentas over a
five year period [253]. A total of 71/2945 (2.4%) abortions caused by Leptospira
were identified. Serovar Pomona was detected more often 40/47 (85.1%) in
fetuses. Serovars Bratislava and Grippotyphosa were detected in 2 and 4
aborted fetuses respectively.
The primary aim of this study is to determine the carrier state of Leptospira
in horses submitted to the University of Kentucky Veterinary Diagnostic
Laboratory for necropsy. Another aim of this study was to ascertain the
prevalence of leptospires in heart blood, kidney, vitreous humor and urine by
both MAT and qPCR. An additional aim was to determine if age, gender and
reason for submission has a role in seroprevalence.

3.2 Materials and Methods
3.2.1 Study Design
Kidney, vitreous humor, heart blood and urine (when available) samples
were collected from 500 horses (6 months or older) brought to the UKVDL for
necropsy. Horses were enrolled within 24 hours after either euthanasia or death.
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Study candidates were not excluded based on sex, status of pregnancy, age or
breed. Clinical, diagnostic and vaccination history for each horse was captured
from the accession form and final diagnostic reports when available. Necropsies
were performed by board certified veterinary pathologists.

3.2.2 Sample Collection and Processing
3.2.2.1 Heart Blood
Heart blood was collected from either the left or right ventricle utilizing a
16-gauge needle, placed in a sterile container, centrifuged and serum was
removed. Serum was stored at 4C prior to analysis. Leptospiral antibody titers
for serovars Pomona, Grippotyphosa and Bratislava were measured by MAT.
MAT was performed in accordance with the methodology of the National
Veterinary Services Laboratories (Ames, IA) and the OIE (World Organization for
Animal Health, 6th edition) Manual of Diagnostic Tests and Vaccines for
Terrestrial Animals Procedure. The reference antigens were propagated in
polysorbate-80 bovine albumin media for 4-8 days and diluted to working
strength on the day of the test. Serum was screened at a 1:50 dilution (in
phosphate buffered saline) in a volume of 50µl in wells of a 96-well flat bottom
plate containing 50µl of diluted antigen. The final serum dilution was therefore
1:100. The plate was incubated at room temperature for 1½ hours. After
incubation the plates were examined for agglutination using dark-field
microscopy. A reaction was deemed positive when 50% of the antigen was
agglutinated. Control sera from horses with known titers were run concurrently
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on each day of testing. Sera that demonstrated at least 50% agglutination at the
screening dilution of 1:100 was serially diluted with their respective antigen to
determine an endpoint titer.

3.2.2.2 Kidneys
A square 2.5 cm x 1 cm section was removed from the caudal and cranial
cortex regions of both kidneys, further sectioned, placed in a sterile container and
frozen at -80C until analyzed. qPCR for L. interrogans was performed utilizing a
validated method at UKVDL on the ABI 7500 Fast instrument (Life
Technologies/Thermo Fisher Scientific, Carlsbad, CA) (Erol et al 2014). See
DNA/PCR section below. Gross and histopathological studies were performed
on all kidneys as part of the routine necropsy.

3.2.2.3 Vitreous Humor
Vitreous humor samples were harvested from both eyes by inserting an 18gauge needle 1 cm caudal to the limbus and aspirating 2 ml from the central
vitreal body. Samples were stored at 4C prior to analysis. MAT was performed
as stated in Heart Blood section. Following MAT analysis, remaining vitreous
sample was stored at -20C pending further evaluation. Real-time PCR for L.
interrogans was performed as stated below.
3.2.2.4 Urine
Urine samples were extracted from the bladder when present (postmortem
changes often fully express all urine from the bladder). Cystocentesis was
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performed using a 14g needle, removing up to 10ml when possible, of urine
(when present) was removed placed in a sterile container and frozen at -80C
until analyzed. Urine samples were processed by two methods [47]. For method
one, urine was thawed, vortexed with 200ul removed and placed in a sterile
container for further DNA extraction. For method two, a second sample (1ml) was
placed in a separate sterile microcentrifuge tube, centrifuged at 12,000g for 10
minutes at 4C. Supernatant was removed and the pellet was reconstituted with
200µl phosphate buffered saline (PBS). DNA was extracted from both methods
at the same time.

3.2.3 DNA Extraction/PCR Analysis: Kidney, Vitreous Humor and Urine
Samples
DNA extraction from all samples was performed using Qiagen DNeasy
Blood and Tissue Kit (Carlsbad, CA) following the manufacturer’s protocol.
Briefly a small section of kidney (~25mg) was removed placed in a MagNa Lyser
Green Bead Tube (Roche Life Science, Indianapolis, IN) with ATL Buffer and
proteinase K solution (Qiagen) and homogenized for 40 seconds using a Roche
MagNA Lyser Instrument. Phosphate buffered saline (PBS) and a sample from a
Leptospira interrogans culture was used as negative and positive controls
respectively. Both positive and negative controls were processed with each
group of samples. Samples/controls were incubated at 56C for one hour,
continuously mixed on a rotating platform and then centrifuged for 5 minutes at
room temperature, 200ul of supernatant was removed and processed using
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QIAcube Nucleic Acid Purification Instrumentation (Qiagen) according to
manufacturer’s protocol. DNA extracted samples were stored at -20C until
analyzed by qPCR. DNA processing of both vitreous humor and urine samples
were processed exactly as kidney samples, using 200ul from each sample.
Real-time PCR was carried out using primers and protocol from an
established procedure [47, 256]. Primers used targeted the LipL32 gene found
only in pathogenic Leptospira. Briefly 2.5µl of DNA sample was added to 22.5µl
of QuantiFast Pathogen PCR +IC (internal control) Kit (Carlsbad, CA) and
0.4µmol/l each of forward (LipL32-45F [CCCGCGTCCGATTAG]) and reverse
(LIPL32-286R [GAACTCCCATTTCAGCGATT]) primers and probe LipL32-189P
(6-FAM AAAGCCAGGACAAGCGCCG-BHQ1). A negative (sterile water) and
positive control (Leptospira interrogans DNA) were included for amplification.
The ABI 7500 Fast qPCR instrumentation (Applied Biosystems-Thermo Fisher
Scientific, Foster City, CA) was used for amplification. The amplification cycle
was one cycle at 95C (5 minutes), 45 cycles of denaturing at 95C (15 seconds),
extension-detection (30 seconds) at 58C. A Ct 30±3 was considered positive for
the internal control, following manufacturers guidelines. Samples were
considered positive with Ct<45.
3.2.4 Animal and Weather Data Collection
The following data elements were collected from the necropsy forms
submitted for each animal if filled out by the submitter, including breed, age, sex,
weight, necropsy results, county/state living at time of death, date of death.
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Weather data was obtained from Midwestern Regional Climate Center
(https://mrcc.illinois.edu) for foaling seasons from June 2015 through May 2019
for the Central Bluegrass region of Kentucky. The Central Bluegrass region for
this study, included the counties of Fayette, Bourbon, Woodford and Scott.
Average monthly temperature and precipitation were acquired.
3.2.5 Statistical Analysis
The association between sex, age, breed, MAT, renal lesions (with or
without the presence of Leptospira), and PCR was calculated using multiple
linear regression. Distribution Analysis was performed on study population by
gender and population by breed. Contingency Analysis and analysis by Fisher’s
Exact Test were used to analyze study population by age, combined results by
gender by titer and age brackets, and MAT heart blood results by gender. Oneway analysis was used to determine breed differences by gender and age.
Differences between gender of MAT titers≥1600 was analyzed using fit least
squares of titer bracket by sex, age bracket and serovar. Differences within
females and pregnancy was determined by Contingency Analysis and further
analyzed by Bowker’s Test and Cochran Armitage Trend Test. All data was
analyzed using JMP 13.2 for MAC (SAS Institute Inc. Cary, NC). P-values ≤0.05
were considered statistically significant.

3.3 Results
Stratification by gender, breed and age are found in Tables 3.1, 3.2 and
3.3 respectively. Representative breeds submitted in the study can be found in
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Figure 3.1. There was no statistical difference in the study population based on
gender. There were 29 (10.5%) females pregnant or had aborted at the time of
death.
There were significantly more Thoroughbreds submitted compared to
other breeds which was anticipated. According to the 2012 census of horses in
Kentucky (Table 3.4), the number of Thoroughbreds in the state and in the
Central Kentucky region was much higher (68.1%) when compared to other
breeds [257].

Table 3.1: Study Population by Gender
Gender

Number

Pregnant

Female

277 (55.4%)

29 (10.5%)

Male

208 (41.6%)

Unknown

15 (3%)

Three age brackets were established as follows: bracket 1≤ 1 year;

bracket 2 is 2 to 12 years; bracket 3≥13 years. Age brackets were chosen to
include foals and yearlings together, the additional two brackets obtained by
averaging the age spread of the horses submitted. Age bracket two had the
highest percent of submissions followed by brackets three and one (46.8%,
21.8% and 12.6% respectively).
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Figure 3.1: Representative Breeds

Table 3.2: Study Population by Breed
Breed

Number

Thoroughbred

353 (70.6%)

Saddlebred

25 (5%)

Quarter Horse

25 (5%)

Standardbred

12 (2.4%)

Other

31 (6.2%)

Unknown

54 (10.8%)
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Table 3.3: Study Population by Age Stratification
Age
Bracket

Total
Number

Female

Male

1

76 (15.2%)

25 (5.0%)

51+ (10.2)

2-12 years

2

231 (46.2%)

123
(24.6%)

108 (21.6%)

≥13 years

3

109 (21.8%)

70++
(14%)

39 (7.8%)

Age
≤ 𝟏𝟏 year

Unknown
59
+ p<0.0001 significantly more younger males
++ p<0.0001 significantly more older females
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Table 3.4: 2012 Equine Survey-Central Kentucky Counties*
County

Total
Equine
Population

TB

SB

QH

SDB

Other

Fayette

24,600

17,510

1240

960

400

1090

Bourbon

13,000

9330

980

380

580

360

Scott

7,000

3170

690

330

680

Woodford

11,900

8440

670

570

670

310

Total

44,800

38450

2890

2600

1980

2440

*2012 Kentucky Equine Survey (Thoroughbred state total=54,000)
TB-thoroughbred; SB-Standardbred; QH-Quarter Horse; SDB-Saddlebred
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The groupings for breed and sex are listed in Table 3.5. Standardbreds
were under-represented compared to Saddlebreds, Quarter horses and
Thoroughbreds. Therefore, they were combined with other known breeds which
were present in very low numbers and unidentified breeds, all were placed into
one group labeled Other. The mean age for both Thoroughbred (p<0.0001) and
quarter horses (p<0.417) was significantly higher in females than their respective
males. The mean age of thoroughbred males was significantly younger
(p<0.0001) when compared within to all other groups.
Table 3.5: Breed Statistics by Gender and Age
Mean
Mean
Mean
Total
Breed
N
Fe*
M*
Age
Age
Age Missing
353
Thoroughbred
7.4 177 9.6+ 125 4.3++++
51
(70.6%)
25
Saddlebred
9
11
7.3
11 111.4
3
(5%)
25
Quarter Horse
10.2
6 14.8++ 17
9.1
2
(5%)
97
Other
11.8 24
11
45
12.7
28
(19.4%)
*Fe (female), M (male)
+p<0.0001
++p<0.0417
+++p<0.0001 within
There was a significant difference (p<0.001) in the number of older
animals (≥13 years) with titers when compared to younger animals (Table 3.6).
Older animals with titers also had significantly higher titers (p<0.001) when
compared to younger animals. There was a significantly higher number of
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females with titers (p<0.0001) compared to males (Table 3.7). Females
additionally had significantly higher titers (p<0.001) compared to males.

Table 3.6: Combined Female and Male Titer Results by Age
Age

Negative Titer=100

≤ 𝟏𝟏 year
67
5
2-12 years
163
20
≥13 years
54
11
Both * and **p<0.0001 to age≤ 1 year

Titer≥ 𝟐𝟐𝟐𝟐𝟐𝟐
9
49*
44**

Table 3.7: Gender by Age and Titer Bracket
Age Bracket

Titer Bracket

Female

Male

1

0

19
(6.9%)

44
(21.2%)

1

1

1 (0.4%)

3 (1.4%)

1

2

5 (1.8%)

4 (1.9%)

2

0

77
(27.8%)

2

1

8 (2.9%)

2

2

3

0

38*
(13.7%)
31
(11.2%)

84
(40.4%)
12
(5.8%)
11
(5.3%)
23
(11.1%)

3

1

5 (1.8%)

6 (2.9%)

3

2

34*
(12.3%)
91**

10
(4.8%)
46

Total Number with titer
*p<0.0005
**p<0.0001
Titer Brackets: 0=negative; 1=100; 2≥200
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3.3.1 MAT Heart Blood
Serovar results for heart blood and results by gender can be found in
Tables 3.8 and 3.9 respectively. There was a significantly higher number of
horses (p<0.0001) with titers to serovar Bratislava compared to Pomona and
Grippotyphosa. Females had significantly higher number of titers to Bratislava
(p<0.0001) compared to males, and within females (p<0.0001). Females also
had a significantly higher number of titers ≥200 compared to males (p<0.0001).
Results within males revealed significantly more males with serovar Bratislava
compared to both Pomona and Grippotyphosa (p<0.0001). Titers ≥100
seroprevalence for Bratislava increased to 25.6%. Both serovars Pomona and
Grippotyphosa only increased slightly to 3% and 5% respectively comparing
titers ≥100 to titers ≥200.

Table 3.8: Serovar-Prevalence in Heart Blood≥200
Serovars

Major
(N=497*

Minor
(N=497) *

Same
(N=497) *

Pomona

14 (2.8%)

22 (4.5%)

8 (1.6%)

Grippotyphosa

21 (4.2%)

12 (2.4%)

2 (0.4%)

Bratislava

90 (18.1%) **

17 (3.5%)

9 (1.8%)

*3 titers were not analyzed
** p<0.0001

Table 3.9: Heart Blood Serovars by Gender
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Serovar/Titer
Bracket

Female

Male

Pomona

15

1

Grippotyphosa

19

5

Bratislava

82*
(29.6%)

41**
(29.7%)

Negative

162

160

Titer=100

19

21

Titer≥200

96***

26

*p<0.0001
**p<0.0001
***p<0.0001

Both sex and age had significant effects on serovar (Tables 3.10-3.12).
Older animals had significantly greater titers (p<0.0001) compared to younger
animals regardless of sex. Females were significantly (p<0.0002) more likely to
have a titer regardless of serovar compared to males.

Table 3.10: Combined Female and Male Positive Serovars by Age
Age
Bratislava Grippotyphosa Pomona
Negative
≤ 𝟏𝟏 year
9
5
0
56
2-12 years
49*
13
7
164
≥13 years
46**
2
8
53
*p<0.0001
**p<0.0001
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Table 3.11: Serovar Results for Female by Age
Total
Female
Female
Age
Female Bratislava Grippotyphosa
≤ 𝟏𝟏 year
25
2 (0.9%)
4 (1.8%)
30
2-12 years
123
9 (4.1%)
(13.8%)*
31
≥13 years
70
2 (0.9%)
(14.2%)*
*p<0.0006
Table 3.12: Serovar Results for Male by Age
Age
Total
Male
Male
Bracket
Male Bratislava Grippotyphosa
≤ 𝟏𝟏 year

Female
Pomona
0
7 (3.2%)
7 (3.2%)

Female
Negative
19 (8.7%)
77
(35.3%)
30
(13.8%)

Male
Pomona

Male
Negative

51

6

1

0

44

2-12 years

107

19*

4

0

84

≥13 years
*p<0.01

39

15*

0

1

23

There were a significantly higher number of Thoroughbreds with titers to
Bratislava compared to all other breeds (p>0.0001) (Table 3.13). Females of
both Thoroughbreds and horses in Other breed category had a significantly
higher seroprevalence to Bratislava compared to males (both p>0.0001).
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Table 3.13: Serovar Bratislava Results by Sex and Breed
Breed/Serovar
Female
Male
Other/Bratislava

20^
(4.1%)*
(7.2%)**
(48%)***
(22%)****

12
(2.5%)*
(5.8%)**
(24%)***
(13.2%)****

Thoroughbred/Bratislava^

57^ (11.8%)*
(20.6%)**
(26%)***
(16.6%)****

21
(4.3%)*
(10.1%)**
(16%)***
(6.1%)****

Saddlebred/Bratislava

2
(0.4%)*
(0.7%)**
(17%)***
(8.3%)****

6
(1.2%)*
(2.9%)**
(50%)***
(25%)****

3
2
(0.6%)*
(0.4%)*
Quarter Horse/Bratislava
(1.1%)**
(0.9%)**
(43%)***
(11%)***
(12%)****
(8%)****
*485 in each group, 15 animals’ unknown sex not included
**within sex
*** within total of breed+sex
****within total of breed
^p<0.0001
The prevalence of titers ≥1600 are listed in Table 3.14. Serovar

Bratislava occurred more often regardless of gender. Females had a significantly
higher number of titers ≥1600 compared to males (p=0.0003).
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Table 3.14: Serovar Titers ≥1600
Serovar
Total*
Female
18
Bratislava
12* (38.7%)
(58.1%)
5
5
Pomona
(16.1%)
(16.1%)
6
(19.4%)
Average Age
15.1 years
*Two samples gender unknown
*p=0.0003

Grippotyphosa

8
(25.8)

Male
5
(16.1%)

1
(3.2)
12.6 years

3.3.2 Pregnancy
There were 29/277 (10.5%) females presented as, in-foal or complications
from abortion for necropsy. There was no significant difference between age of
non-pregnant (NP) and pregnant mares (P) (9.8 and 12.1 years respectively).
The titer bracket distribution of NP compared to P-mares are in Figures 3.2 and
3.3 respectively. A larger percent of NP-mares (61%) were negative (bracket
zero) compared to 34% of P-mares. There was no difference between NP and
P-mares in titer bracket one (titers=100) with 6% and 10% respectively. Titer
bracket two (titer≥200) comprised 32% NP and 55% of P-mares. P-mares had
significantly higher titers compared to NP-mares (p<0.0318) (Figure 3.4). Both
NP and P-mares had a significantly higher number of positive titers to serovar
Bratislava (p<0.0079) compared to the other serovars. Non-pregnant mares with
titers ≥1600 regardless of serovar verged on significance (p<0.067) compared to
P mares (Figure 3.5). The number of non-pregnant and pregnant mares with

titers ≥1600 was low (18 and 5 respectively). A greater number of samples is
needed for any conclusions to be reached.
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Figure 3.2: Distribution of Non-Pregnant Mares by Titer Brackets

152, 61%
80, 32%
16, 6%
0

1

2

Figure 3.3: Distribution of Pregnant Mares by Titer Brackets

16, 55%
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0

1
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Figure 3.4: Analysis of Titer Brackets by Pregnancy

*
2

titer bracket

1.5
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0
0
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Figure 3.5: Female Serovar Titers ≥1600 by Pregnancy
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3.3.3 Vitreous
Serovars and titers detected in vitreous samples and corresponding heart
blood titers are listed in Table 3.15. There were 4 vitreous samples with titers
≥100. Three out of four had titers to Bratislava in both the heart and vitreous
samples. Only one vitreous sample had a titer to Pomona, the heart sample was
negative.
Table 3.15: Vitreous Humor and Heart Blood Titers
Serovar
Bratislava

Pomona

Vitreous

Heart

N

Titer

Titer

1

6400

6400

1

200

12,800

1

100

1600

1

100

0

3.3.4 Real-Time PCR Testing
There were 496 kidney samples tested by qPCR, one sample was
positive. A total of 73 urine samples were tested, all were negative. Only 3/455
vitreous samples were positive by qPCR, none had elevated titers.

3.3.5 Precipitation and Temperature
No differences were seen with time of year, titers and increases in
temperature and/or precipitation (data not shown).
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3.4 Discussion
The objective of this study was to determine the seroprevalence of
Leptospira in the general population of horses submitted to the VDL for necropsy
regardless of sex, age, breed or pregnancy status. The VDL receives serum
samples from farms beginning in October through March to monitor leptospiral
titers in pregnant mares. Titer evaluations are performed to detect rising titers,
which could lead to abortion and assisting in the decision whether or not to
employ a prophylactic antibiotic treatment. Titers are rarely evaluated on nonpregnant mares or male horses. Leptospiral titers may be analyzed on other
horses if uveitis, ERU, renal disease or septicemia are occurring (personal
communication-Dr. Craig Carter, UKVDL).
The current study found no significant differences between the number of
female and male submissions to the VDL. Looking at equine submissions
between 2010-2020 to the VDL, other years have shown the same pattern
(Appendix 4). The number of Thoroughbreds was significantly higher when
compared to all other breeds (known and unknown) combined. This was a
predictable outcome for the Central Kentucky region. The number of
Thoroughbreds submitted mirrors a survey of the equine industry which showed
approximately 68% of horses in Central Kentucky area are Thoroughbreds [257].
The majority of horses were in three breed groups (70.6% Thoroughbred,
5% Saddlebred, 5% Quarter horses). The mean age of male to female
Thoroughbreds was significantly lower. Examining age brackets between
gender, there was a significantly higher number of males ≤ 1 year compared to
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females and higher number of females 13 years compared to males. Regarding
breed submissions, males had a significantly higher number of young
Thoroughbreds submitted for fractures, compared to any other breed. Males
also had a significantly higher number of fractures compared to females. Males
in this study consisted of 24% of total submissions in age brackets 1 and 2. A
significantly higher number of males were submitted for fractures and Wobbler
Syndrome. One reason for increased number of young males with fractures
might be an escalation in aggressiveness leading to accidents in paddock areas
(personal communication-Dr. Jennifer Janes, UKVDL). Wobbler Syndrome has
been shown to be significantly higher in males compared to females [258].
The number of titers ≥ 200 were seen in older horses. Published

research shows as a horse ages, titers appear to become established and
environmental exposure to Leptospira over many years increases this risk [41,
237]. Healthy horses as they age (>7 years) have been shown to have increased
titers compared to younger horses (<3 years) [185, 202, 259]. One study
showed an increase in seroprevalence by 10% for every year a horse ages [202].
Combining females and males there were no significant difference
between the number of horses with titers in age brackets 2 and 3. However,
when separating the genders, significant differences can be seen. There was a
significantly higher number of females with titers compared to males. Previous
research has shown this, and could be due to females pastured together more
often than males [260]. This allows females to have increased exposure to
wildlife and each other, potentially increasing exposure to Leptospira. Females
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had significantly higher titers compared to males. A reason behind a higher
number of females with increased titers is age stratification. Males had a
significantly higher number in age bracket 1 compared to females. Horses in age
bracket 1 had either no titer or very low titers. Females had a significantly higher
number in age bracket 3 compared to males.
Differences between gender are observed in serovar prevalence. There
were significantly more horses with titers to serovar Bratislava compared to both
Pomona and Grippotyphosa. These results are similar to previous studies in
both North America and Europe. As early as 1981 serovar Bratislava was found
to be the most prevalent serovar (31.7%) in a random group of horses for export
from England [261]. Others in Canada, US and Europe have also found this
serovar to be more prevalent [177, 259, 262]. The horse is thought to be the
maintenance host for serovar Bratislava, although subclinical infections are
thought to be prominent [86, 186]. Clinical infections caused by serovar
Bratislava have occurred [177]. A study in Croatia found over 28% of serum
samples from horses had titers to serovar Bratislava [263]. Recently a study
published in 2018 showed over 47% of horses in the Midwest (specifically
Kansas, Missouri, and Nebraska) had titers of ≥ 100 to serovar Bratislava [199].

A significantly higher number of females had titers to Bratislava compared

to males, and within females. Females also had a significantly higher number of
titers ≥200 compared to males to serovar Bratislava. Considering gender and
age there was a significant effect on serovar. Females were significantly more
likely to have a titer to all three serovars. Once again, this phenomenon may be
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due to the way females are grouped together. Males are typically either alone or
grouped in very small numbers.
The high incidence of serovar Bratislava in this study has been previously
documented in Kentucky. On one Kentucky horse farm, a 53% seroprevalence
of Bratislava was observed [264]. In another study, horses from three Central
Kentucky farms had a 33% seroprevalence to Bratislava [230]. A study
conducted in 2011 analyzed 50 serum samples for leptospiral titers submitted to
the VDL for reasons other than leptospirosis [203]. These samples were part of
a larger study evaluating the prevalence of equine leptospirosis in the US and
one province of Canada. The study demonstrated 38/39 (97.4%) of samples in
Kentucky with a titer ≥100 to Bratislava, with only one sample having a titer with
Grippotyphosa. The study separated out geldings from stallions, which

demonstrated 75% of stallions had negative titers compared to 87.5% geldings
with a titer ≥100. There were no significant differences between gender

regardless of separating out geldings from stallions or grouping them together.
There was no difference between gender and serovar prevalence. The
outcomes between the 2011 and this study may be due to the differences in
breeds represented. The present study had significantly more Thoroughbreds
(70.6%) compared to only 8.5% in the 2011 study. Both studies had no
significant differences in the number of females vs males. Another difference
was the time of year the samples were taken. All samples in 2011 were collected
in April compared to samples taken throughout the year in the current study.
Typically, in the Central Kentucky area the highest number or horses with titers
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occurs between the months of October and March [30, 87, 254]. When looking
at age in the 2011 study (not age bracket) females (mean=12.4) are significantly
older compared to all males (p=0.0155) (mean=8.9).
The current study had significantly more female Thoroughbreds with a
seroprevalence to Bratislava compared to males and all other breeds. Also,
females in the Other category had a significantly higher seroprevalence to
Bratislava compared to males. A study published in 2009 showed similar results
[185]. However, in the 2009 study, geldings and stallions were analyzed
separately. If they had grouped all males, it appears there would have not been
a difference. The suggestion was mares spend more time out in the field
together compared to males (especially stallions) therefore exposing them to
increased risk of exposure to Leptospira.
Racoons have long been associated with the spread of Leptospira [265,
266]. Racoons in the state of Kentucky are legally hunted for their pelts.
However, over the past several decades hunting racoons has decreased
dramatically due to the value of the pelt plummeting (personal communication-Dr.
Matthew Springer, University of Kentucky). The number of raccoons in the state
have increased dramatically directly related to decreased hunting. Several
studies have shown raccoons have a high percent of seroprevalence to serovar
Bratislava. A study in Indiana found over 38% seroprevalence to serovar
Bratislava in raccoons [266]. A second study in Illinois found over 28%
seroprevalence to serovar Bratislava in raccoons [29]. One can speculate this
may contribute to the increased occurrence of leptospiral titers and possibly
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clinical leptospirosis not only in horses but other mammals. A study conducted in
Kentucky isolated Leptospira interrogans serovar Pomona type Kennewicki in
4/14 raccoons [267].
Leptospirosis in horses is endemic in Kentucky. Veterinarians practicing
in Kentucky consider titers ≥1600 indicative of a possible infection or a major
exposure. In this study, females had a significantly higher number of titers

≥1600 and neither age nor serovar had a significant impact on the level of titers.
Pregnant mares had significantly higher titers (not titer brackets) after taking into
consideration unequal variances. There were no other significant differences
within the female group. Mares are immune compromised in the last trimester of
pregnancy, therefore titers may increase during this time period, after multiple
exposures to Leptospira environmentally and/or by direct contact with other
animals. Stress caused by increased leptospiral titers and transplacental
infection may increase chances for abortion [86].
Only 4 horses had positive titers in the vitreous, none considered to have
an active infection according to the Goldmann-Whitmer coefficient. The low
number of vitreous samples with a titer is not surprising since none of these
animals were euthanized because of blindness or ERU. However, there were 14
vitreous samples with a green fluorescent color indicating they had recently had
an ophthalmological exam. All fourteen horses had negative titers in both their
heart and vitreous samples. A high percent of horses in this study were
Thoroughbreds. Although they can present with ERU, they have not been found
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to have a genetic link like Appaloosas [214, 216]. Also, a lower percent of
Thoroughbreds present with ERU compared to other breeds [214, 217].
Urine samples were collected from 16% of animals, all were negative by
PCR. Identification of leptospires through culture or PCR from urine samples is
difficult because of the sensitivity of the organism to pH and enzymatic
breakdown in the urine. Additionally, all samples were taken from deceased
horses resulting in a collection of urine which might reduce detection by PCR.
Studies have shown positive results for Leptospira by PCR in urine upon
collection from live horses especially after abortions caused by leptospirosis
[167, 268, 269].
There are a number of limitations to this study. Samples were taken at the
time of death. In addition, there were no paired serum sample collections to
determine whether horses with titers ≥1600 might indicate a current recent

leptospiral infection (fourfold rise in titer). Multiple serum titers are critical in
determining leptospirosis and its course. Only 73/500 (14.6%) urine samples
were analyzed, all negative by PCR. The low number along with only one
sample from each horse makes it difficult to draw conclusions about shedding of
leptospires in the horse. A small section of kidney was taken for analysis. Lack
of isolation from the kidney could have been due to missing potential tubule(s)
containing the organism from the section taken at necropsy and subsequent DNA
isolation.
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3.5 Conclusions
Horses submitted for necropsy between May 2016 to January 2019 have
evidence of exposure to Leptospira (elevated MAT titers) regardless of the
reason for submission. There was a higher seroprevalence of serovar Bratislava
compared to both Pomona and Grippotyphosa. This has been seen previously in
Kentucky [203, 230]. Further research is needed to determine the strains of
Bratislava in the US and their differences, if any, to Europe. Females compared
to males appear to have an increased risk of having significantly higher MAT
titers. This may be due to housing of mares together compared to males which
tend to be either alone or in smaller numbers. This could also be specific to
Central Kentucky. Further research is needed to ascertain whether this is
occurring only in this region or is common throughout the US and/or globally.
Older horses are more likely to have a titer for Leptospira and also have higher
titers. This has been documented in multiple papers [41, 185, 202, 237, 259].
PCR results were negative for pathogenic Leptospira in urine, with a low number
of positive kidney and vitreous samples. This suggests that the risk of leptospiral
shedding of the organism in urine by horses in Central Kentucky is minor and
possibly indicates that horses clear leptospiral infections quickly. Results also
suggest the risk of humans/animals acquiring a leptospiral infection from horses
without an active infection is low. However, only one sample was
analyzed/animal with no previous or follow up samples for comparison in order to
determine the occurrence of an active infection. Therefore, further research is
needed to confirm these findings.
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Chapter Four

Heme Oxygenase-1: A Novel Marker for Equine Leptospiral Abortion?

4.1 Introduction

Heme oxygenase (HO) is an enzyme with three known mammalian
isoforms: HO-1, HO-2 and HO-3 [270-273]. HO-1 is found throughout the body
but is highly expressed in the liver, spleen and places with high red blood cell
(RBC) turnover [270, 274]. HO-1 concentrations are very low or undetectable
under normal conditions, but highly inducible under inflammatory conditions and
stress. HO-2 is expressed constitutively in mammals [272, 274]. HO-2 is highly
expressed in many tissues such as kidney, liver, testes, spleen, and the nervous
and cardiovascular systems [274, 275]. HO-2 is thought to be neuroprotective in
the brain and play an important role in male reproduction [275]. HO-2 is also
thought to be involved in the maintenance of basal heme metabolism. Unlike
HO-1, information about HO-2 is limited due to the lack of selective chemical
probes to study the enzyme [275]. HO-3 is thought to be a pseudogene derived
from HO-2 transcripts and has only been identified in rat brain [273]. The
function of HO-3 is still unknown.
HO-1 deficiency in humans was first noted in a young boy with a multitude
of developmental disturbances, including hemolytic anemia, low bilirubin,
abnormal coagulation, intravascular hemolysis, severe growth impedance along
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with many other maladies all traced back to HO-1 deficiency [276].

A HO-1

deficiency in mice was associated with a number of problems including abortion,
increased inflammatory responses, lymphadenopathy and splenomegaly [277].
Deficiency in HO-1 in mammals leads to the inability to respond to inflammatory
processes. The body’s failure to respond with a proper immune response can
lead to an exaggerated inflammatory response [277]. In cases of organ
transplantation, it will lead to rejection. The importance of HO-1 in both adaptive
and general oxidative stress in mammalian cells was confirmed in the mid-1980s
[278]
The increasing interest and importance of HO-1 can be appreciated by
the number of articles published over the past 30 years. In 1992 there were 8
articles published (PubMed), since 1993 there have been well over 10,000.

4.2 Heme Oxygenase-1
HO-1 is upregulated by numerous chemicals, inflammatory cytokines and
is found in various tissues, bone marrow and cells [279-281]. It has been
detected in various mammals including humans, rats, mice, swine, sheep and
bovine [282-288]. HO-1 is an enzyme involved in the biosynthesis of heme and
is the first and rate-limiting step of the oxidative degradation of heme. The byproducts of the reaction produce carbon monoxide (CO), free iron and heme
precursor biliverdin (BV), which subsequently is converted to bilirubin (BR) [278,
279, 289]. HO-1 and HO-2 can degrade heme into its by-products, however only
HO-1 can be induced by a large number of chemicals and drugs, such as metals,
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eicosanoids, aspirin, statins and niacin [290]. The by-products of HO-1 are antiinflammatory, reducing organ injury. Additionally, they assist in maintaining
heme at normal levels [291]. HO-1 is involved in vascular tone, anti-inflammatory
processes, anti-apoptotic responses, responding to and reducing oxidative stress
leading to decreased tissue damage in numerous organ systems [288].

4.3 Hemoglobin
Hemoglobin (Hb) is a protein found in red blood cells [292]. In humans
approximately 1% of Hb is degraded daily. The main function of Hb is the
storage and transport of oxygen [293, 294].
There are differences in equine Hb as compared to humans and
ruminants. Horse Hb has a lower binding affinity to oxygen than humans, but
higher than ruminants [295, 296]. Oxygen affinity is important for the quick
release and delivery of oxygen to tissues and is pH dependent [293, 296].

4.4 Equine Red Blood Cells
The average life span of RBCs in the horse is 140-150 days compared to
120 days in humans [292, 297]. Red blood cells have many roles, the main one
is carrying O2 from the lungs throughout the body to tissues, organs, muscles
and to carry CO2 back to the lungs for exhalation. RBCs in humans and horses
both release and rapidly uptake amino acids, which represent 15-17% of their
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total content [297]. This indicates another role for RBCs, transporting amino
acids throughout the body.
Equine RBCs vary among breeds [298]. There are key differences in
RBCs between hot-blooded and cold-blooded breeds. Hot-blooded horses
include Arabian, Standardbred, Quarter horses, Thoroughbreds and Appaloosas
[298]. Cold-blooded breeds include ponies, hackneys, draft horses and donkeys.
Table 4.1 shows RBC differences in hot- and cold-blooded equine breeds and
humans.

Table 4.1: RBC Differences Between Hot- and Cold-Blooded Horses
Unit
Hot-Blooded Cold-Blooded
Humans
Parameter
Horses
Horses
Female
Male
12
RBC
8.2-12.2
5.5-9.5
4.2-5.4
4.6-6.2
X10 /L
Hemoglobin
g/L
130-170
80-140
115-160 140-180
PCV
percent
32-48
24-44
MCV
fL
36-50
40-48
80-95
80-95
MCH
pg
13-19
12-17
MCHC
g/L
330-390
320-380
300-340 300-340
5.7
5.7
6.2-8.2
6.2-8.2
Diameter
µm
PCV=packed cell volume
MCV=mean corpuscular volume
MCH=mean corpuscular hemoglobin
MCHC=mean corpuscular hemoglobin concentration
RBCs in the horse are unique in forming a rouleaux configuration [298].
The RBCs aggregate together linearly, with the number of rouleaux formations
attributed to the number of RBCs in circulation. Figure 4.1 shows RBC rouleaux
formation in horses. Normally, RBCs have a strong negative charge and repel
each other [298]. However, in horses the charge is weak, causing them to stack
together into the rouleaux formation and have the propensity to aggregate in
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anticoagulated blood samples. Increased rouleaux formation can be seen in
certain diseases such as hyperproteinemia [298].

Figure 4.1: Rouleaux Formation in Equine RBC*

*[298]

4.5 HO-1: Physiology and Immune Response
HO-1 is crucial for an oxidative stress response in humans [278]. HO-1
can act as an agonist or antagonist depending on conditions and upregulation
upon stimulation [278]. Stimulation can be an inflammatory process or trauma
(protective). One indicator of HO-1 trauma is bruising of the skin. When trauma
occurs blood capillaries break releasing RBCs [278]. The RBCs will lyse, a
red/brown color on the skin occurs caused by hemoglobin/met-hemoglobin. The
yellow/green color is then generated by the release of biliverdin.
During oxidative stress HO removes free heme decreasing the over
production of reactive oxygen species (ROS) [299]. If left unchecked, free heme
will undergo autooxidation to produce superoxide and hydrogen peroxide with
94

further development to ROS. HO-1 is well known to demonstrate cytoprotective
effects upon stress related conditions [277, 278, 300]. When oxidative injury
occurs, be it from infection, cardiovascular event, trauma, inflammation or organ
transplants, HO-1 is modulated. HO-1 breaks down heme releasing CO and
biliverdin, which execute their own antioxidant/anti-inflammatory properties
concurrently with HO-1 downregulating pro-inflammatory cytokines [277, 301,
302].
Both tissue and cell damage/injury occur through lipid peroxidation and
free radical formation if heme is left unchecked by HO [291, 303]. HO-1
metabolizes high amounts of heme, elevating by-products and leading to tissue
damage [303]. Major damage can occur in the kidney by heme overload. The
heme proteins can form a precipitant in the renal tubules, compromising the
filtration system of the kidneys and potentially leading to renal failure [303].
A number of transcription factors control HO-1 including nuclear factor
kappa-light-chain-enhancer of activated B cells (NF-kB), c-Jun NH2-terminal
protein kinase (JNK) and activator protein 1 (AP-1) (Appendix 6) [303]. These
transcription factors can be activated by iron, heme and free radicals. Free iron
in the ferrous form is a strong pro-oxidant and one of the breakdown products of
heme. The ferrous form is used in a number of processes to facilitate free radical
formation, and in the Fenton reaction [303]. The Fenton reaction drives the
production of free radicals. Fenton reaction can also stimulate the production of
ferritin which acts as an antioxidant by binding to iron and releasing it in a precise
manner [304]. Ferritin is an iron storage protein found in many cells and tissues
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in mammals, and in bacteria [304, 305]. Ferritin also has cytoprotective
properties [299]. The amount of ferrous iron produced is dependent on the
amount and availability of heme and induction of apoferritin [303, 306].
Apoferritin is a protein when bound to iron, forms ferritin. HO-1 control of heme
prevents program cell death of parenchyma cells by co-expression of ferritin H
chain (FTH) [304]. FTH controls the pro-oxidant effect of Fe after its’ release
from the protoporphyrin IX ring of heme. Transcription factor JNK is continually
activated by the intracellular accumulation of free radicals; however FTH controls
JNK activation and in a feedback mechanism JNK activation inhibits FTH,
controlling the cellular overload of Fe [304]. All of this centers on availability and
regulation of HO-1.
HO-1, like nitric oxide, can be detrimental by unchecked degradation of
heme and accumulation of its by-products [291]. HO-1 can downregulate nitric
oxide synthase (NOS), and NOS can up and down regulate HO through multiple
pathways including NF-kB [291, 307]. Dysregulation of either HO or NOS can
lead to detrimental effects such as tissue and vascular damage.
Interleukin-10 (IL-10) is a cytokine that influences multiple cell types with a
wide range of effects [301, 308]. Notably IL-10 has the ability to inhibit proinflammatory cytokines such as interleukin-1 beta (IL-1β), interleukin-6 (IL-6),
interleukin-8 (IL-8) and tumor necrosis factor alpha (TNFα). IL-10 has also been
shown to induce HO-1, and there appears to be a synergistic effect between IL10 and HO-1 [302]. When HO-1 is restricted, the inhibitory effect of IL-10 on proinflammatory cytokines is reduced. HO-1 can be induced by TNFα, IL-1β, IL-6,
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IL-8 and IL-10 [271]. HO-1 along with its by-products has also been shown to be
important in not only the maintenance of pregnancy in humans, but also in
protection against eclampsia and uterine contractility [274, 302]. IL-10 is also
important in maintaining pregnancy.

4.6 Pregnancy
4.6.1 Humans
HO-1 has been well documented regarding the vasculature of the uterus
in humans, mice and rats [271, 281, 284, 309]. HO-1 supports and stabilizes the
implantation of the embryo at conception and has a protective effect throughout
pregnancy [281, 285, 309, 310]. HO-1 protects the placenta in immune
tolerance/suppression between the fetus and mother, decreasing oxidative stress
during pregnancy [311].
HO is found in the basal plate, chorionic villi, fetal membranes and the
chorionic plate during pregnancy in humans [282, 288]. HO-1 has also been
identified in human vascular endothelium, syncytiotrophoblast and
cytotrophoblast cells. The regulation of HO in the placenta is partly dependent
on localized amounts of glucose and oxygen [312]. An in vitro study showed
increases in HO-1 after cells were deprived of glucose and oxygen for 24 hours,
and subsequently exposed to low concentrations of both [312]. The blood
vessels in the placenta are not innervated, consequently vascular tone is
controlled by localized soluble factors such as CO [312]. The placenta can
overcome low oxygen by undertaking anaerobic glycolysis, however this will
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increase oxidative stress. In order to maintain homeostasis, levels of HO will
increase to protect the placenta from by-products of anaerobic glycolysis [312].
Preeclampsia (PE) can also cause complications in blood flow to the uterus and
placenta, causing a deficiency in both glucose and oxygen, thereby increasing
oxidative stress [312].
HO-1 and breakdown products of heme, namely CO and biliverdin, are
important for maintenance throughout pregnancy [311]. There is an increased
concentration gradient between the maternal and fetal circulation of biliverdin and
bilirubin further indicating a role of HO [313]. Biliverdin cannot cross the
placental barrier like bilirubin, however both the placenta and uterus (pregnant)
can reduce biliverdin to bilirubin for transfer [313]. Once transfer occurs, bilirubin
can serve as an antioxidant. During pregnancy there is increased oxidative
stress with trophoblast cells in contact with the maternal vascular system [285].
The trophoblast cells carry oxygen and have the ability to cross the placenta
barrier to the growing fetus [314]. Low levels of HO can lead to increased levels
of heme at the fetal-maternal interface increasing an inflammatory response.
The occurrence of fatty acids (FA), specifically polyunsaturated FA, have
been found in the plasma of human umbilical cord, increasing chances of
oxidation and fetal injury [288]. The amount of FA in fetal circulation is lower
when compared to an adult. The polyunsaturated FAs are susceptible to
oxidation placing the fetus at increased risk of oxidative damage [288].
Both nitric oxide (NO) and HO have been found in humans, rats and mice
at implantation, and are essential in trophoblast attachment and maintenance
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[281, 288]. Increased oxidative stress in the fetus initiates an increase in both
iNOS and HO-1 [315].
HO-1 is a stress response protein upregulated at pregnancy [282]. The
critical period in pregnancy is the implantation of the trophoblast cells into the
uterine wall. The uterine wall is extremely hypoxic with 1-2% oxygen, little
vasculature, and an increased immune response during pregnancy [282]. In
humans HO-1 and exhaled CO levels are lower in the placenta of women with
PE compared to normal pregnancies [311, 316].
Several studies have shown a decrease in HO and spontaneous
abortions in humans [314, 317]. Levels of HO-1 and HO-2 were decreased in
trophoblasts from aborted fetuses compared to trophoblasts from terminated
normal pregnancies. In a case study of 3 deleterious pregnancy outcomes, a
homozygous deletion was found in the HMOX1 gene (HO-1) leading to a
frameshift and a premature termination codon [318]. This mutation was carried
by both parents and to abortion and/or termination of each pregnancy.

4.6.2 Mice/Rats
Studies in mice have demonstrated the importance of HO-1 in maintaining
pregnancy from early development through birth [319, 320]. In these models, as
HO-1 decreased circulating levels of t-helper cell-1 (TH-1), while proinflammatory IL-1β, TNFα and IFNg, increased [283]. In mouse models of
abortion, levels of HO-1 in the placenta have been shown to decrease along with
circulating IL-10 [310, 321, 322]. Supplementing abortion prone mice with HO-1
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adenoviral vector has been shown to decrease levels of pro-inflammatory
cytokines [281, 313, 322]. In both mice and rats a Th1 response triggers an
elevation of IL-2, TNFα and IFNg cytokines, and the loss of the fetus may occur
[283, 323]. When a Th2 response occurs, increases in IL-4 and IL-10 have been
shown to protect and maintain the pregnancy through birth. In HO-1 knockout
mice abortion will occur even if Th2 cytokines have been upregulated [283]. HO1 and its by-products are essential for maintaining pregnancy, protecting against
eclampsia and uterine contractility in humans and other mammals [281, 313].
HO-1 has also been shown to play an important role in bacterial infections that
cause abortion, such as Listeria monocytogenes [324].
The equine immune response during pregnancy has been well
documented [325-327]. The importance of HO-1 in the horse is yet to be
determined. Preliminary data (presented below) shows an increased level of
both HO-1 and IL-10 in pregnant mares, and mares with increased MAT titers to
Leptospira. The studies below were undertaken to determine the normal serum
levels of HO-1 in the horse. By establishing the basal levels of HO-1 we hope to
determine changes, if any, when horses become ill or pregnant, to avert potential
serious life-threatening disease and/or abortion.
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4.7 Materials and Methods
4.7.1 Pilot Study
In 2015 there were no published papers referencing serum HO-1 levels in
horses. Therefore, a preliminary study was undertaken to determine if HO-1
could be measured. The literature indicates HO-1 is upregulated in pregnancy
and/or infections in humans, rats and mice. The farm chosen for the study
recently had cases of leptospirosis confirmed by University of Kentucky
Veterinary Diagnostic Laboratory in pregnant mares.
4.7.1.1 Study Design
Blood samples were collected from 9 mares by the resident veterinarian
on one farm for four consecutive weeks during 2015. The first blood samples
taken were 20-40 days after 6 mares were bred. Three mares included in the
study were not pregnant and had been bred 3 months before the study but came
up empty at day 28 post breeding (30+days prior to first sample). Samples were
submitted to the VDL and analyzed for leptospirosis by microagglutination test
(MAT), centrifuged and serum was removed. Serum was stored at 4C prior to
MAT analysis. Samples were stored at -20C after MAT analysis. One additional
sample was taken 294 days from day one. MAT was performed in accordance
with the methodology of the National Veterinary Services Laboratories (Ames, IA)
and the OIE (World Organization for Animal Health, 6th edition) Manual of
Diagnostic Tests and Vaccines for Terrestrial Animals Procedure. The reference
antigens were propagated in polysorbate-80 bovine albumin media for 4-8 days
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and diluted to working strength on the day of the test. Serum was screened at a
1:50 dilution (in phosphate buffered saline) in a volume of 50µl in wells of a 96well flat bottom plate containing 50µl of diluted antigen. The final serum dilution
was therefore 1:100. The plate was incubated at room temperature for 1½
hours. After incubation the plates were examined for agglutination using darkfield microscopy. A reaction was deemed positive when 50% of the antigen was
agglutinated. Control sera from horses with known titers were run concurrently
on each day of testing. Sera that demonstrated at least 50% agglutination at the
screening dilution of 1:100 was serially diluted with their respective antigen to
determine an endpoint titer. Leptospira reference serovars used included
Canicola, strain Hond Utretcht IV; Copenhageni (Icterohemorragica reference)
strain M-20; Grippotyphosa, strain Andaman; Hardjo, strain Hardjoprajtino; and
Pomona, strain Pomona.
Serum samples were also analyzed by Enzyme-Linked Immunosorbent
Assay (ELISA) for the following: Equine IL-10, Catalog#GR106003 (Genorise
Scientific Inc., Glen Mills, PA; https://www.genorise.com) and Equine HO-1,
Catalog#MBS019561 (MyBioSource, San Diego, CA;
https://www.mybiosource.com). ELISA tests were carried out following
manufacturer’s instructions; both standards and samples were run in duplicate.
The sensitivity of the IL-10 assay is 2pg/ml with a detection range of 62000pg/ml. The intra and inter-assay coefficient of variation is 5% and 8%
respectively. The sensitivity of the HO-1 ELISA kit is 0.1ng/ml and range of
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detection is 0.625-20ng/ml. Both the intra- and inter-assay coefficient of variation
is less than 15% for HO-1 assay.

4.7.1.2 Statistics
Statistical analysis was carried out using student’s t-test and least squares
fit (JMP v12, SAS, Cary, NC). Confidence levels were set at 95%.
Funding: This study was supported by a grant from the Southeast Center for
Agricultural Health and Injury Prevention, via NIOSH/CDC Cooperative
Agreement U500H007547.
4.8 Results
MAT, IL-10 and HO-1 data are listed in Tables 4.2 and 4.3 respectively.
The primary serovar identified was Pomona. There was a significant difference
in HO-1 (p<0.002) levels in Leptospira positive compared to negative mares and
pregnancy alone showed a significant difference in HO-1(p<0.02), but not in IL10 concentrations (Figure 4.2).
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Table 4.2: MAT Pilot Study Results
Animal

Pomona
Day 1

Pomona
Day 7

Pomona
Day 21/Day
14*
51,200

Mare
Negative
102,400
P
1
Mare
Negative
102,400
102,400
2P
Mare
Negative
NA
204,800
3P
Mare
Negative
51,200
51,200
4P
Mare 5 Negative
12,800
51,200
Mare 6
100
100
100
Mare 7
1660
3200
1600
Mare
400
400
800
P
8
Mare
100
100
100
P
9
P=Pregnant; NT=not tested; ND=Non-detectable
*Day 21 for mares 1-5 and Day 14 for mares 6-9

Pomona
Day 28

Pomona
Day 294

51,200

1600

102,400

1600

NT

1600

51,200

1600

12,800
NT
NT
NT

100
ND
ND
ND

NT

ND

Day 28

Day 294

Table 4.3: IL-10 and HO-1 Pilot Study
Day 1
Animal
Mare
1P
Mare
2P
Mare
3P
Mare
4P
Mare 5
Mare 6
Mare 7
Mare
8P
Mare
9P

Day 7

Day 21/Day
14*
ILHO-1
10

IL10

HO-1

IL10

HO-1

IL10

HO-1

IL10

HO-1

9.6

3.9

11.9

2.3

15.3

3

11.9

3.2

16.9

1.3

0.66

4.4

0.98

4.3

2.9

5

3.7

3.9

4

1.7

9.4

4.5

10.6

3.6

10.6

4.2

10.9

3.9

5.1

BDL

4.2

3.6

3

3

4.4

3.5

3

BDL

0.91

BDL

2.5
8
BDL

0.86
1.1
2

6.4
9.6
4.1

5.2
1.4
1

1
10.3
BDL

1.2
1.4
BDL

1.4
BDL
BDL

3.4

3.3

1.4

3.3

0.66

1.3
NT
NT
NT

2.1
14.4
2.2

BDL

3.4
NT
NT
NT

2.6

2.4

BDL

2.6

3.5

1.8

5.2

1.5

NT

NT

2

0.91

BDL=below detectable limit; P=pregnant; NT=not tested
*Day 21 for mares 1-5 and Day 14 for mares 6-9
IL-10 and HO-1 reported in ng/ml
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12000

Figure 4.2: Pilot Study Levels of IL-10 and HO-1 Levels in Leptospira
Positive and Negative Mares
+

10000
8000
6000
4000

IL-10

*

HO-1

***

**

Leptospira positive and
Not Pregnant

Pregnant and Leptospira
Negative

Pregnant and Leptospira
Positive

Not Pregnant

Pregnant

Leptospira Negative

Leptospira Positive

0

Leptospira negative and
Not Pregnant

2000

IL-10 and HO-1 reported in pg/ml
*p<0.002; **p<0.009; ***p<0.04; +p<0.04

There was no significant difference in either IL-10 or HO-1 levels in barren
mares regardless of Leptospira state. When comparing HO-1 levels in pregnant
mares over time, there was a significant difference between day 1 and 7
(p<0.03), and day 1 and 28 (p<0.04). Additionally, HO-1 at day 294 in the
pregnant mare group was significantly different in all the days (day 1 p<0.0002;
day 7 p<0.002; day 14 p<0.01) except for days 28 and 294. There is a significant
correlation on both day 1 (p<0.003) and day 21 (p<0.02) in pregnant horses, as
MAT levels increased so did HO-1 levels, when compared to non-pregnant
mares. There were no significant correlations detected for IL-10 to MAT levels in
either group.
This is the first study to show a response to HO-1 in both pregnant/nonpregnant mares, with/without increased leptospiral titers. The significance of this
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protein in either pregnancy or infection in horses is yet to be determined.
However, this pilot study has shown HO-1 could be detected and differences do
appear to occur with pregnancy and leptospiral infection. This study laid the
foundation for the larger study which follows.

4.9 Determination of HO-1 Levels in Horses Located in Central Kentucky
4.9.1 Materials and Methods
4.9.1.1 Study Design
The pilot study showed HO-1 could be measured in equine serum, this larger
study was undertaken to identify the following:
1. Determine HO-1 levels in healthy non-pregnant mares in Central Kentucky
2. Determine HO-1 levels in mares in three groups:

4.9.1.2 Animals
4.9.1.2.1 Group One
The following samples were submitted to the University of Kentucky
Veterinary Diagnostic Laboratory (VDL) for leptospiral screening titers. All serum
samples were fresh and from pregnant mares except for two samples from foals.
1. MAT titers of ≥25,600 to either serovar Pomona or Grippotyphosa:
64 mares fit this requirement and 1 sample from each mare was
analyzed except for the following:
a. 9 mares had two samples within one month, both analyzed
b. 2 samples were foals
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4.9.1.1.2 Group Two
Serum samples for Group Two were provided by Dr. Barry Ball, University
of Kentucky, Professor of Veterinary Science. All serum samples in Group Two
had been frozen at -20oC.
4.9.1.2.2.1 Control: 51 healthy mares not pregnant, located on the
University of Kentucky’s Research Farm were designated as the
control group. One sample from each mare was analyzed. Sample
times varied from February 2013 to February 2018, with the majority of
samples collected between the months of May-July.
4.9.1.2.2.2 Field: 44 pregnant mares were included in this group.
These samples were collected from horses located on farms in Central
Kentucky. Samples analyzed were collected from 7 months of
pregnancy till foaling or abortion. Twenty pregnant mares were
separated into two groups of 10, designated as field with and without
supplement (Table 4.4). The supplement given was Altrenogest, a
synthetic progestin. The remaining 24 pregnant mares had a number
of different conditions listed in Table 4.5. One sample from each mare
in this group were analyzed at the following time points of pregnancy:
c. 7 months
d. 9 months
e. After foaling/abortion
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Table 4.4: Field Samples
Group
Number of Mares
Field
No Supplement
10
Supplement
10
Case
24

Table 4.5: Field Samples-Case
Diagnosis
Number of Cases
Umbilical torsion
1
Placentitis
2
Bacterial Placentitis
2
Nocardioform Placentitis
2
Mild acute placentitis
1
Mild focal placentitis
2
Inconclusive
1
Viral Placentitis-EHV-1
1
Mild placentitis-dystocia
2
Idiopathic
1
Separation
1
Minimal
1
placentitis/amnionitis
Chronic focal bacterial
1
placentitis-Nocardioform
Placenta previa-foal
1
dead separation
Focal, chronic placentitis
1
Bacterial and mycotic
1
yeast placentitis
Minimal focal suppurative
1
placentitis
Focal severe bacterial
1
placentitis
Amnionitis and funistis
1
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4.9.1.2.2.3 Pregnant mares over time: 18 healthy mares located on
the University of Kentucky’s Research Farm, were included in this
group. All mares carried to full term. One serum sample from each
mare at the following time points of pregnancy was analyzed:
f. Initial sample day 15 -April 2012
g. 75 days-June 2012
h. 250 days-November 2012
i.

310 days-January 2013

j.

325 days-January 2013

k. 340 days-January 2013

4.9.1.2.3 Group Three
1. A group of pregnant mares that had aborted due to leptospirosis were
also analyzed. Leptospiral Positive Mares who aborted: 34 mares
had aborted because of confirmed leptospiral infection (samples
provided by Dr. John Timoney, Professor University of Kentucky
Veterinary Science Department). One sample from each mare was
analyzed.

4.9.2 Serum Sample Processing
4.9.2.1 MAT Analysis
Fresh blood samples for MAT were submitted to the University of
Kentucky’s Veterinary Diagnostic Laboratory (Group One), centrifuged and
serum was removed. Serum was stored at 4C prior to MAT analysis. Samples
were stored at -20OC after MAT analysis. Serum samples were analyzed for
leptospirosis using MAT. MAT was performed in accordance with the
methodology of the National Veterinary Services Laboratories (Ames, IA) and the
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OIE (World Organization for Animal Health, 6th edition) Manual of Diagnostic
Tests and Vaccines for Terrestrial Animals Procedure. The reference antigens
were propagated in polysorbate-80 bovine albumin media for 4-8 days and
diluted to working strength on the day of the test. Serum was screened at a 1:50
dilution (in phosphate buffered saline) in a volume of 50µl in wells of a 96-well flat
bottom plate containing 50µl of diluted antigen. The final serum dilution was
therefore 1:100. The plate was incubated at room temperature for 1½ hours.
After incubation the plates were examined for agglutination using dark-field
microscopy. A reaction was deemed positive when 50% of the antigen was
agglutinated. Control sera from horses with known titers were run concurrently
on each day of testing. Sera that demonstrated at least 50% agglutination at the
screening dilution of 1:100 were serially diluted with their respective antigen to
determine an endpoint titer. Leptospira reference serovars used included
Grippotyphosa, strain Andaman and Pomona, strain Pomona.

4.9.2.2 HO-1 Analysis
Serum samples for HO-1 analysis were acquired as followed: Frozen
serum samples for control, field samples and pregnant mares over time (Group
Two) were provided by Dr. Barry Ball, University of Kentucky, Professor of
Veterinary Science, Lexington, Kentucky (samples collected between 20132018); frozen serum samples from leptospiral positive mares who aborted (Group
Three) were provided by Dr. John Timoney, University of Kentucky Professor of
Veterinary Science, Lexington, Kentucky (samples collected between 1991-
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1998). Fresh serum samples submitted to UKVDL between November 2017 and
January 2018 were also analyzed.
Samples for HO-1 analysis were processed as follows: samples were
analyzed by ELISA for the following: Equine HO-1, Catalog#MBS019561
(MyBioSource, San Diego, CA; https://www.mybiosource.com). ELISA was
carried out following manufacturer’s instructions; both standards and samples
were run in duplicate. The sensitivity of the HO-1 ELISA kit is 0.1ng/ml and
range of detection is 0.625-20ng/ml. Both the intra- and inter-assay coefficient of
variation is less than 15%.

4.9.3 Statistical Analysis
One of the primary reasons for this study was to determine the normal
levels of HO-1 in horses in order to identify changes related to stressors such as
pregnancy and illness. A power analysis for one-way independent ANOVA was
performed to determine the number of animals needed for a significant difference
at p=0.05, 216 animals were included with a total of 340 samples analyzed for
HO-1. All HO-1 samples were analyzed using ELISA kits from the same lot
number.
UKVDL samples were analyzed using a one-way ANOVA for differences
between MAT serovars, and serovar/HO-1 results. The effect of serovar and titer
was determined by Standard Least Squares. Nine samples taken a month apart
were analyzed using Matching Pair.
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Field samples were analyzed using one-way ANOVA for non-pregnant
control mares and time of estrous. Field samples overtime were analyzed using
MANOVA. Tukey’s Means Comparison was used to analyze any differences
amongst field samples and between leptospiral survey samples. All samples
were analyzed using JMP v13.2 (SAS, Cary, NC). Significance was set to
p≤0.05.

4.10 Results
4.10.1 Group One: UKVDL Leptospiral Survey Samples
Results for HO-1 are in Table 4.6. There were no differences seen with
serovar/MAT and HO-1 outcome.

Table 4.6: UKVDL Leptospiral Survey
Number
Effect of
Serovar
of
Serovar
Samples
Pomona
62
None
Grippotyphosa
3
None
*p=0.0437

Effect of
Titer

HO-1
(µg/ml)

None
None

8.3
5.5

Serovar Pomona had significantly higher titers compared to serovar
Grippotyphosa (p<0.0437). Additionally, 9 animals had serum analyzed a month
from the initial sample. Seven of these were mares and 2 were foals. Eight had
elevated titers to serovar Pomona (two foals and 6 mares), and 1 to
Grippotyphosa. Results in Table 4.7.

112

Table 4.7: Matched Paired MAT/HO-1
Horse Number

Serovar

1

Pomona

2

Grippotyphosa

3

Pomona

4

Pomona

5

Pomona

6-Foal

Pomona

7

Pomona

8-Foal

Pomona

9-Mare Aborted

Pomona

MAT Titer
First
Second*
25600
12800
25600
12800
51200
12800
51200
12800
51200
12800
102400
51200
204800
102400
204800
12800
102400
204800

*Taken one month after first sample
**ng/ml
***Above standard curve, both removed prior to statistical analysis

HO-1**
First
Second*
7.0
10.5
3.7
5.7
3.3
5.8
5.8
3.4
3.4
6.4
47***
7.4
7.4
8.3
43***
6.4
19.6
11.9

Using Matching Pair analysis within and among pairs by titer and HO-1, a
significant difference was seen (p=0.0411). As titer went down HO-1 went up in
5/7 mares, all were still pregnant at the time of the second blood collection. One
mare (#9) had an increased MAT titer, but HO-1 decreased. The second sample
was taken after she aborted. MAT titers and HO-1 levels for both foals
decreased. There was no change looking at differences by serovar overtime. A
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Oneway analysis and using Tukey-Kramer HSD Means Comparisons of HO-1 by
titer showed a significant difference between mares with MAT titers of 102,400
and 51,200 (p=0.0412).

4.10.2 Group Two
Results for control mares (healthy and not pregnant) can be found in
Table 8. The mean HO-1 levels for control mares were 5.6µg/ml. There were
12/39 (23.5%) samples above the standard curve, excluded from statistical
analysis and not included in Table 4.8. There were no significant differences in
HO-1 in mares who were in estrous and those who were not.
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Table 4.8: Control Mare Field Samples
Sample
Number
1
3
4
5
6
7
8
10
11
12
13
15
16
17
18
20
21
22
23
25
26
27
28
29
30
33
34
35
36
37
38
39
41
44
45
48
49
50
51
*ng/ml

Days in
Estrous

12

6
8
3
2
12
12
0
1
12

8
14
6
12
6
6
9
12
10
6
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HO-1*
3
8.1
6.7
1.7
2
11.4
0.85
1.8
1
3.6
0.44
3.2
2.9
8.3
4.5
4.1
4.5
15
9.2
1.7
3.1
1.8
4
8.5
3.4
2.3
2.9
2.2
7.2
13
19.7
4.2
4.9
2.8
3.5
17.6
17.9
3.1
3

Samples were acquired from mares in the Field group (pregnant with and
without supplement, and case) over a period of four months, starting in
December of 2013 through May 2014 (actual start date of samples varied from
mare to mare). Comparison of means for initial, midway and the last blood
sample taken (time of foaling/abortion) are in Table 4.9. Comparing mares in this
group only (those with and without supplement) to case mares, there were no
significant differences over time between or within groups using MANOVA.
Table 4.9: Field Samples Over Time-HO-1*
Group
All
Initial
Middle
Samples
HO-1
HO-1
Control
6.6
NS
6.2
7.3
S
5.6
6.3
Case
6.8
7.6
6.1
NS=No supplement
S=Supplement
*ng/ml

Last
HO-1
8.1
6.4
5.7

Mean HO-1 results for field samples (no supplement, supplement and case) of all
samples taken over 4 months are in Table 4.10. There were no significant
differences between groups.
Table 4.10: Field Study No Supplement, Supplement and Case HO-1
Group
HO-1*
No Supplement
7.2
Supplement
6.1
Case
6.8
*ng/ml
Results for mares pregnant over time are in Table 4.11. There were 18
mares in this group. Blood samples were drawn on the following days of
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gestation: 15, 75, 250, 310, 325 and 340 depending on time of foaling. Results
were averaged according to the day of sample collection. There was no
significant difference regardless of days of gestation.

Table 4.11: Mares Pregnant Over Time-HO-1
Day of Gestation
HO-1*
15
5.1
75
5.7
250
5.5
310
5
325
4.9
340
6.2
*ng/ml
Results for control, pregnant overtime and field samples (combined no
supplement/supplement) can be found in Table 4.12. There were no significant
differences.

Table 4.12: Control, Pregnant Overtime and Field Sample
Group
HO-1*
Control
4.7
Pregnant Overtime
5.4
Field
Control-NS+S
6.6
Case
6.8
*ng/ml
Results from control, pregnant mares overtime, field samples (no
supplement, supplement and case) and leptospirosis survey samples can be
found in Table 4.13. There was a significant difference between leptospirosis
survey samples and control (p<0.0017) and pregnant overtime (p<0.0011).
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Table 4.13: Field, Pregnant Overtime and Leptospira Survey
Group
HO-1*
Not Pregnant (Control)
4.7
Pregnant Overtime
5.4
Field
No Supplement
7.2
Supplement
6.1
Case
6.8
Leptospirosis Survey Samples
8.3**+
*ng/ml
**p<0.0017 to Not Pregnant (Control)
+p<0.0011 to Pregnant OT

All field (no supplement and supplement) carried to term. The average days of
gestation in the field group with no supplement was 333.4 days compared to
328.4 days in the supplement group. Field case mares had 6 abortions (2 never
made it to start of study, no blood samples were taken). A total of 18/24 mares in
the case group carried to full term. The average gestation was 342 days,
although including 6 mares who aborted the average gestation was 332.3 days.
Comparing gestation days (including all case mares and those that aborted)
there was no statistical difference within the field group. However, if the 6 mares
who aborted using Tukey-Kramer HSD means comparisons are excluded, there
is a significant difference between case/supplement (p=0.0067).
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Table 4.14: HO-1 Levels: Field, Pregnant Overtime, Leptospirosis
Survey and Leptospirosis/Mares Aborted
Group
HO-1*
Not Pregnant (Control)
4.7
Pregnant Overtime
5.4
Field
No Supplement
7.2
Supplement
6.1
Case
6.8
Leptospirosis/Mares Aborted
5.2
Leptospirosis Survey Samples
8.3**+#
*ng/ml
*p<0.0016 to Not Pregnant (Control)
+p=0.001 Pregnant OT
#p=0.0232 Leptospirosis/Mares Aborted
4.10.3 Group Three
When samples from mares who had been identified with leptospirosis and
aborted were compared to all others there was a significant difference only for
leptospirosis survey samples (p<0.0232) results are in Table 4.14.

4.11 Discussion
The role of HO-1 in horses has not previously been elucidated. A pilot
study was conducted in 2015 to determine if HO-1 levels could be detected in the
serum of horses. HO-1 levels in non-pregnant mares were significantly lower
compared to pregnant mares. These results are consistent with literature in both
humans, rats and mice showing an increase in HO-1 levels during pregnancy
[282, 299, 317]. The last sample taken (day 295) was after foaling and shows a
decrease in HO-1 similar to what has been shown in other mammals [313, 328].
These data concur with HO-1 levels in other mammals that are pregnant and
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have underlying maladies such as PE, hypertension and other disease entities
[318, 328, 329].
The first part of this project examined HO-1 levels in pregnant mares
screened for leptospirosis through UKVDL. By the time the second study was
initiated an equine leptospiral vaccine, specific for serovar Pomona had been on
the market for two years. Data have shown MAT titers post-vaccination in horses
are around 1600, but titers up to 6400 have been seen [330]. Because of this,
horses submitted were required to have titers ≥25,600. Regardless of serovar or
MAT titer, HO-1 mean level was the same for Pomona and Grippotyphosa.
Sixty-four horses were included in this part of the study and only 9 had an
additional sample analyzed for comparison. The small sample size (N=9) makes
it difficult to conclude if there truly is no difference between the dominate serovar
and HO-1 levels. The host and its response to the prevailing serovar will
determine the severity of infection by MAT [331]. Differences in host response
have been seen depending on infective serovar [86, 157, 185]. The HO-1
response to bacterial virulence can be detrimental to the host (Vasil 1999; Chung
2008). A larger study is needed to determine the extent to which the infective
serovar affects HO-1 levels.
Seven mares and two foals had two samples analyzed a month apart.
MAT levels in 8/9 animals decreased over one month, however only 4/9 showed
a decrease in HO-1 levels. Decreased levels in 3/4 were the foals and a mare
who had aborted. These three show a similar trend seen in other mammals.
Both animals and humans have shown a decrease in HO-1 right before and after
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abortion has occurred [283, 285, 314]. HO-1 has been shown to decrease
overtime after infections [332, 333]. The small subset of animals (N=9) and
smaller number who showed a decrease in HO-1 (N=3), makes it impossible to
determine if this is the same in horses. A larger study is needed to determine if
this is also true in horses. The second MAT titer analyzed from the mare who
aborted increased while HO-1 decreased, showing pregnancy may influence HO1 levels more than infection in horses. Increases in HO-1 levels in 5/9 mares
whose MAT titers decreased also shows the influence pregnancy has on HO-1
levels. This has been seen in other pregnant mammals with bacterial infections
[324, 334, 335].
Estrous cycle in Group Two-healthy nonpregnant mares showed no
differences in HO-1 levels compared to mares not in estrous. These results are
different compared to other mammals such as mice and rats. In both rats and
mice HO-1 has been shown to increase during estrous [336, 337]. In mice higher
levels of HO-1 occur during metestrus [337]. Mares in the field group were
divided into 3 groups (control no supplement, control supplement and case).
Control mares with or without supplement and case mares showed no significant
differences in HO-1 levels over a period of 20 weeks. This concurs with results
seen in the leptospiral survey group. Pregnancy seems to play a greater role in
HO-1 levels than infection. A majority of mares in the case group (79%) had
placentitis, regardless their HO-1 levels were very similar to mares who had no
known health issue.
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Mares pregnant overtime also showed no significant differences
regardless of the day of gestation. Nor were there any differences comparing
this group to the field mares, this strengthens the concept HO-1 levels are
influenced more by pregnancy. Case mares who aborted did not show any
decrease in HO-1 levels prior to abortion, seen in other mammals.
The leptospirosis survey samples had significantly higher HO-1 when
compared to non-pregnant and pregnant overtime mares. The significantly
higher HO-1 in leptospiral survey mares maybe due to the type of bacterial
infection in addition to pregnancy. The length of gestation of mares in the
leptospiral survey group were unknown, which could also have influenced HO-1
levels. Both field case and leptospiral survey mares had significantly higher HO1 levels when compared to nonpregnant mares. In other mammals HO-1 is
upregulated during infection [274, 279, 338]. Increased HO-1 levels have been
shown in infections caused by Corynebacterium, Pseudomonas, Listeria,
Acinetobacter and others [339-341]. Bacteria, viruses and fungi also have heme
oxygenase, including those bacteria previously mentioned [339, 342]. The HO
found in bacteria is needed for the breakdown of heme and uptake of iron. Iron
is essential for the bacteria’s pathogenicity, virulence, colonization and survival
[341]. The host attempts to limit free iron by the use of iron-binding molecules,
however bacteria have developed ways to circumvent the limited availability.
Some bacteria have outer membrane receptors for ferrous iron such as
Campylobacter jejuni [341]. Other bacteria, such as Pseudomonas, secrete
siderophores that bind ferrous iron and can transport it back into the bacteria
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[343]. Still others acquire iron by the degradation of heme through heme
oxygenase. Leptospira have HO and require it for the breakdown of heme in vivo
and to establish colonization in the host [344-346]. Leptospira can bind to heme
through the hemin-binding protein (HbpA) [347-349]. Heme oxygenase gene in
pathogenic Leptospira (hemO) is also required for host pathogenicity [345].
Leptospira acquire iron from heme needed for growth in vivo from the host [350].
Both case and leptospiral survey groups had higher levels of HO-1. This could
be due to additional breakdown of heme by the bacteria or viral infections
ongoing in these mares. Specifically, the leptospiral survey group had
significantly higher levels of HO-1 than any other group analyzed. Leptospira
have been shown to be one of the leading causes of placentitis leading to
abortion in central Kentucky [255]. Leptospira cause a consistent diffuse
placentitis compared to any other causes of placentitis. Large numbers of
spirochetes can be found throughout the placenta and this diffuse placentitis
originates from hematogenous [255]. It is possible with the increased flux of
blood caused by Leptospira in the placenta, host HO-1 is also upregulated, and a
feedback loop occurs by Leptospira causing increased bleeding and spirochetes
utilizing heme, thereby increasing their proliferation. A similar feedback loop has
been proposed in Pseudomonas [351]. The upregulation of HO-1 and cytokines
by pregnant mares with leptospiral infection may also protect from abortion.
In Pseudomonas and Neisseria infections, heme oxygenase (HemO) have
a smaller solvent-accessible surface when compared to human HO. Both have
less than 15% homology to human HO-1 [270]. Small antimicrobial molecules
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against this site may have potential to inhibit these bacteria from pathogenicity
and proliferation. In Pseudomonas’s HemO an additional binding site has been
identified, where a small molecule with a lipophilic group can possibly bind the
hydrophobic pocket [270]. The binding would impair the HemO stability/activity
of the enzyme by stopping the initial hydroxylation of the heme group [352].
Recently the use of a gallium(III)-salophen has shown promise to inhibit both the
HO and iron uptake in Pseudomonas [351]. Similar structures are now being
investigated with Leptospira [346]. The crystal structure of Leptospira HemO
shows several key areas used to block the enzyme activity. By targeting these
differences found only in bacterial heme oxygenase may be one method to stop
progression of infection.
HO-1 in other mammals is upregulated in the placenta under normal
pregnancy [311, 353]. HO-1 gene (HMOX1) has been detected in the placenta
of mares [354]. HMOX1 in the equine placenta is upregulated and appears to
stay constant through gestation. A study evaluating gene expression in the
equine placenta from 45 days gestation to 10 months showed no difference in
HMOX1 during this time period [354].
Serum HO-1 levels in this study ranged from 0.44ng/ml to 47ng/ml. Nonpregnant mares had the lowest HO-1 average (4.7ng/ml). HO-1 levels in
humans have been shown to range from below 0.5ng/ml to 10.1ng/ml [355-357].
HO-1 average serum levels in pregnant healthy women in one study was
1.9ng/ml, while non-pregnant controls levels averaged 3.5 [355]. Another study
showed average HO-1 levels in healthy pregnant women was 1.8ng/ml [356].
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There can be several reasons for the differences between HO-1 levels seen in
humans vs horses in this study. ELISA kits from different manufacturers were
used which can lead to discrepancies. Also, the differences in RBC and
hemoglobin between humans and horses can be contributing factors. Rouleaux
formation, increased number of RBCs and lower oxygen binding in horses may
all be contributing factors in higher HO-1 levels compared to humans.
The mare’s gestation is unique compared to other mammals, including
humans. Relaxin is produced in the mare’s placental trophoblast cells and
concentrations increase in late gestation and increase further during labor [358,
359]. Whereas in swine the corpora lutea is the major site of relaxin during
pregnancy [360]. Breed differences of relaxin have been seen in horses during
pregnancy. Relaxin in Thoroughbreds was undetectable until day 80, levels rise
till day 175 then decline to day 225 and increase until foaling [359]. Whereas in
Standardbreds increases occurred till day 150 and slowly declined until foaling.
Relaxin in humans and mares is important in for vasodilation and maintaining the
placenta during pregnancy [361, 362]. In women and dogs, lower levels of
relaxin occur when symptoms of approaching miscarriage during early pregnancy
are seen [360]. The mare has a specialized area between the yolk sac and
chorioallantois forming the chorionic girdle made up of trophoblastic cells, which
is visible ~gestation day 25 [363]. The chorionic girdle transports nutrients and
hormones between the uterus and placenta. Trophoblast cells in humans
contribute to HO-1 levels in the placenta [353]. The HO-1 levels in this study
tended to show an increase till mid-late gestation followed by a decrease and an
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increase towards foaling. This is not what has been shown in other mammals.
The HO-1 levels seem to follow relaxin levels shown in pregnant mares. The
increase in trophoblasts between the yolk sac and chorioallantois may also be
contributing to these differences HO-1 levels in mares. Vascular endothelial
growth factor (VEGF) has been shown to require HO-1 activity [309]. Relaxin
has also been shown to be strongly associated with VEGF [364-366]. Both
relaxin and HO-1 are critical in regulation of angiogenesis during pregnancy and
are regulated by MAPK and p38 pathways [309, 365]. Relaxin gene (RLN) in the
horse has been shown to be highly upregulated from 45 days to 10 months of
gestation [354]. The importance of both HO-1 and relaxin in angiogenesis
increases their association during pregnancy in mares. Further studies are
needed to ascertain the connection between relaxin and HO-1 in mares.
Limitations of this study include the use of several studies from different
years. Not having a study from start to finish carried out is subject to additional
variations, including sample handling and storage and variation of parameters in
studies.
This study showed HO-1 in the serum of horses is upregulated in both
mares pregnant with significant leptospiral MAT titers and with placentitis.
Further studies are needed to determine HO-1 progression before, during and
after normal pregnancy and any complications during pregnancy. Additional
studies are also needed to ascertain the increase in HO-1 levels in mares who
are pregnant and have high MAT titers to Leptospira, and complications that may
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occur if HO-1 levels decline. The importance of HO-1 in infection in horses and
pregnancy in the mare requires further research.
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Chapter 5
Discussion and Future Studies
5.1 Discussion and Future Studies
Leptospirosis in mammals continues to cause global morbidity, mortality,
animal welfare concerns, and economic losses. Developing countries, which can
least afford the economic losses, are the most affected. Developed countries
including the United States (US) have seen an increase in the past 20 years in
morbidity, especially among domestic animals. The low incidence of
leptospirosis in humans in the US led to CDC removing it from the notifiable
disease list in 1990s. However, leptospirosis was placed back on the list in 2013
due to a rise in both animal and human cases.
Compared to developing countries, the US has typically reported low
numbers of leptospiral cases for both animals and humans. A concern is that
leptospirosis is not being considered in the differential diagnosis list. In many
parts of the world, leptospirosis is considered endemic, therefore the diagnosis
and tracking of outbreaks are routine. The value of a near-real-time monitoring
system for disease outbreaks has been underscored by the recent COVID-19
pandemic. Because leptospirosis is a zoonotic disease, monitoring incidence in
animals is critical. Improved understanding of the epidemiology and clinical
presentation of leptospirosis by both veterinarians and physicians will aid in
successfully identification of cases.
The changing climate, including increasing temperature and precipitation,
favors the increased presence of leptospires in the environment [150]. Several
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recent peer-reviewed scientific articles have cited climate change as an
accelerator of active clinical cases of leptospirosis [73, 246]. Therefore, tracking
and confirming diagnoses is increasingly more important, not only for
leptospirosis, but other endemic and emerging microbial diseases. Even with the
advent of vaccines, animal cases have been on the rise. There are some data
suggesting that leptospirosis vaccines are not widely utilized. For example, in
dogs the vaccine can cause a mass to form at the injection site, causing some
owners and veterinarians to want to avoid the vaccine. Other possible causes of
perceived decreased effectiveness of the vaccines are serovar drift, increased
testing, urbanization and climate change.
Chapter Two examined the frequency of leptospiral diagnosis in equine
and bovine cases by AAVLD laboratories in the US. The number of submissions
for leptospiral testing in 17 states varied by a wide margin, from 1 up to
2731/year. This discrepancy likely reflects the difference in testing from state to
state or lack of centralized reporting of the disease. As has been mentioned, the
inconsistency in the number of cases tested and diagnosed in the US may reflect
the lack of suspicion of cases by veterinarians, meaning the incidence may be
higher. More active surveillance for the disease over time would provide a
clearer representation of leptospirosis in animals. Additionally, educating the
general public about leptospirosis, risk of infection, and preventive measures
(e.g. vaccines), would increase awareness and could lead to decreasing
infections in both animals and humans.
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Equine leptospirosis continues to be a problem in Central Kentucky.
However, with the advent of a vaccine in 2015 an apparent decrease in the
number of abortions has been seen. However, controlled studies need to be
done on horse farms to determine the ability of the vaccine to prevent and control
equine leptospirosis. Chapter Three emphasized leptospiral seroprevalence in
the general equine population of Central Kentucky. Over 25% of horses tested
have a positive titer ≥200, suggesting that horse exposure to Leptospira is

common in Central Kentucky. A significantly greater number of females had
titers compared to males. Separating out females in pastures may help eliminate
exposure/re-exposure. Decreasing exposure to wildlife can also help mitigate
exposure and risk for becoming infected by Leptospira.
Since 2009, 89 leptospiral abortions have been confirmed by the UK
Veterinary Diagnostic Laboratory, most of which occurred in Central Kentucky
[367]. Serovar Pomona str. kennewicki is the main cause of equine abortions in
Central Kentucky, with Grippotyphosa playing a minor role. Seroconversion to
serovar Bratislava has been seen in Central Kentucky since the mid-1980s [87].
Identification of serovar Bratislava by culture has never been reported in the US
equine population yet the serovar has been isolated frequently in Ireland and
Great Britain [157, 177]. Early papers published from samples collected in
Central Kentucky from aborted fetuses showed an occasional abortion caused by
serovar Bratislava diagnosed by MAT [254]. One plausible reason the strain of
serovar Bratislava seen in the US hasn’t been isolated could be it is transient in
horses and does not colonize any organs. Increased titers to the serovar which
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occur often could be from repeated environmental exposure only. Bratislava may
not colonize the kidneys therefore short or long-term shedding is not seen. A
recent paper looking at colonization of serovar Bratislava could not isolate the
organism after repeated inoculations, however increased titers were seen [368].
One reason for this outcome could have been the strain used was isolated from a
pig in 1989 with repeated freeze/thawing. The swine strain used may not be able
to colonize the horse at all and increased titers showed seroconversion only,
which is frequently seen. The study didn’t start collecting samples until day 3
possibly missing the time of shedding. To truly know whether serovar Bratislava
is a problem in horses the organism needs to be isolated and studied to
determine its’ ability to colonize in an organ. Studies looking at shedding should
start at day zero (inoculation day) to see if the organism is passing through
immediately (between days 0-3) indicating an immune response but no
colonization. The horse has long thought to be host adapted to serovar
Bratislava; however recent genotyping has found this may not be true [157].
Since 1985 the change in precipitation and temperature in Central
Kentucky has been significant. Looking at 5-year increments,
precipitation/temperature has changed from 40.3”/55.4oF in 1985-1989 to
56.3”/57.7oF in 2015-2019, Figure 5.1. Temperature was not seen as significant
by statistical analysis, but a change in over 2oF is considered significant in this
period of time [67]. This change maybe causing environmental pressure on
serovars seen globally and in Central Kentucky.
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Figure 5.1: Five-Year Averages for Temperature and Precipitation in
Fayette County, Kentucky 1985-2020
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p=0.0446 between 1985-1989 and 2015-2019
Changes in serovar prevalence on samples submitted to a diagnostic laboratory
have occurred in the state over time from
Icterohaemorrhagiae/Bratislava/Grippotyphosa/Pomona (49.1%, 76.3%, 20.1%
and 15.9% respectively) in 1989/1990 to Bratislava/Grippotyphosa/Pomona
(18.1%, 4.2% and 2.8% respectively) in this study (Table 1) [230].
Table 5.1: Serovar Prevalence in Central Kentucky
Serovar
%Prevalence
%Prevalence
1989/1990
2016/2019
Icterohaemorrhagiae
49.1
Bratislava
76.3
18.1
Grippotyphosa
20.1
4.2
Pomona
15.9%
2.8%
Isolation and molecular identification of Bratislava in horses has been reported
but not in the US [184, 188]. Reproductive problems and poor health in horses
has been associated with serovar Bratislava [184, 369]. Further studies in the
US need to be undertaken looking at reproductive problems and poor health, and
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their possible association with serovar Bratislava. Exposure and increased titers
to serovar Bratislava may not cause abortion but could be associated with
reproductive and general poor health in horses.
Methods to attempt to detect and prevent leptospiral abortion was the
focus of the research in Chapter Four. Heme oxygenase-1 (HO-1) and its’ role in
pregnancy and infection has been studied in humans and several other
mammalian species, but until now, not in horses. HO-1 in horses does not fully
follow what occurs in other mammals. This study showed it is significantly
upregulated in horses who have elevated leptospiral MAT titers and are
pregnant. Pregnant horses had increased HO-1 levels as compared to nonpregnant mares and increased further in mares who are pregnant and have
placentitis. Compared to other mammals, HO-1 in mares in this study didn’t
decrease prior to foaling. The decrease in other mammals appears to be part of
the preparation of the placenta for labor. Why this doesn’t occur in horses
requires further research. HO-1 in the mare could be closely tied to relaxin which
also does not decrease prior to foaling but increases similar to HO-1. Further
studies are indicated in the role HO-1 contributes not only to pregnancy, but also
with infection in the horse.
Leptospirosis continues to remain a challenge for the equine industry in
the US but also globally in humans and animals. It appears that the changing
climate will increase these challenges as this bacterium continues to change and
adapt to its environment, potentially making it more difficult to prevent
infection[60].
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Appendix 1
Leptospiral Vaccines

Table One: US Leptospiral Vaccines
Boehringer
Species
Zoetis
Ingelheim
Bovine
Hardjo
Hardjo
Pomona
Pomona
ICT*
ICT
Canicola
Canicola
Grippotyphosa Grippotyphosa
Ovine
Caprine
Swine

Canine

Hardjo
Pomona
ICT
Canicola
Grippotyphosa
Bratislava
Pomona
ICT
Canicola
Grippotyphosa

Elanco

Merck

Hardjo
Pomona
ICT
Canicola
Grippotyphosa

Hardjo
Pomona
ICT
Canicola
Grippotyphosa

Pomona
ICT
Canicola
Grippotyphosa

Pomona
ICT
Canicola
Grippotyphosa

Hardjo
Pomona
ICT
Canicola
Grippotyphosa
Pomona
ICT
Canicola
Grippotyphosa

Equine
Pomona
*ICT=Icterohaemorrhagiae
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Table Two: Non-US Leptospiral Vaccines
Species
Bovine

Virbac (New
Zealand)
Hardjo,
Pomona
Copenhageni

Zoetis
(Australia)
Hardjo
Pomona

Ovine

Hardjo
Pomona

Caprine

Hardjo
Pomona

Swine

Hipra (Brazil)

M-Laboratorios
Microsules
Hardjo
Hardjo
Wolffi
Wolffi
Icterohaemorrhagiae Icterohaemorrhagiae
Bratislava
Pomona
Pomona
Canicola
Copenhageni
Grippotyphosa
Tarassovi
Pyrogenes
Bataviae
Wolffi
Icterohaemorrhagiae
Pomona
Canicola
Copenhageni
Grippotyphosa
Tarassovi
Pyrogenes
Bataviae
Wolffi
Icterohaemorrhagiae
Pomona
Canicola
Copenhageni
Grippotyphosa
Tarassovi
Pyrogenes
Bataviae
Wolffi
Icterohaemorrhagiae
Pomona
Canicola
Copenhageni
Grippotypohsa
Tarassovi
Pyrogenes
Bataviae
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Appendix 2

BD/DIFCO EMJH Base Medium*
Ingredient
Albumin
Polysorbate 80
Disodium phosphate (buffering agent)
Monopotassium phosphate (buffering agent)
Sodium chloride
Thiamine (growth factor)
Ammonium chloride (nitrogen source)

Amount/L
1gram
0.3gram
1gram
0.005gram

pH 7.5±0.2
*https://legacy.bd.com/ds/technicalCenter/inserts/S1368JAA(201107).pdf?_ga=2.
167973857.1115642891.1605379874-2065563281.1605379874

BD/BBL Leptospira Enrichment Media**
Ingredient
Long-chain fatty acids
Thiamine B1)
Cyanocobalamin (B12)
Lyophilized rabbit serum

Purpose
Carbon and energy source
Growth and energy
Hemoglobin

**https://www.bd.com/en-us/support/bd-life-sciences-diagnostic-systemspackage-inserts
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HIMEDIA
EMHJ Base Medium
Ingredient
Disodium hydrogen orthophosphate
(buffering)
Monopotassium phosphate (buffering)
Sodium chloride (osmotic equilibrium and
essential ions)
Ammonium chloride (essential nutrients
for growth)
Thiamine
pH (25oC) 7.5±0.2
Himedia: Leptospira Enrichment Media (add 1vial/180ml sterile water then add
to base media)***
Ingredients
Calcium chloride
Magnesium chloride
Zinc sulphate
Copper sulphate
Ferrous sulphate
Vitamin B12
Bovine serum albumin
Polysorbate 80
Glycerol
Distilled water
Final pH at 25oC is 7.2±0.2

***http://www.himedialabs.com/TD/FD066.pdf (enrichment website)
+

http://himedialabs.com/TD/M1009.pdf (base media)
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Horsnby and Nally Media++
HAN media
BSA 10g
Thiamine chloride 1ml,
0.5g/100ml water
Calcium chloride
1ml,
3g/100ml
Magnesium chloride
1ml, 3g/100ml
Zinc sulphate
1ml, 0.4g/100ml
Hemin
10ml, 6.52mg/100ml
Vitamin B12
1ml, 0.02g/100ml
Tween 80
12.5ml, 10ml/100ml
Glycerol
1ml, 10% solution in water
Ammonium Chloride
1ml, 25% solution in water
Disodium phosphate
1g
Monopotassium phosphate
0.3g
Sodium chloride
1g
Sodium pyruvate
0.1g
5-Fluoruracil
100ug/ml
Dulbecco’s Modified Eagle’s Medium/Ham’s Nutrient Mixture F12
pH 7.4Made up to 1L and filtered sterilized

200ml

Hornsby, R.L., D.P. Alt, and J.E. Nally, Isolation and propagation of leptospires
at 37 degrees C directly from the mammalian host. Sci Rep, 2020. 10(1): p.
9620.
++
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APPENDIX 3
Survey Sent to AAVLD Accredited Laboratories

1. Does your lab run MAT for leptospirosis?
! If YES to #1 what serovars can/does your lab run
! If YES to #1, on average, about how many serum samples does
your lab receive per year for MAT testing
" Break out numbers for bovine and equine samples
2. On abortion necropsies, does your lab run an FA or PCR to rule-in/out
leptospiral abortion?
3. On average, how many lepto abortions are confirmed in your laboratory
each year
! Break out numbers for bovine and equine samples
4. On equine uveitis cases, does your lab run a FA or PCR on aqueous
humor to rule-in/out a leptorspiral etiology?
5. On average, how many equine recurrent uveitis cases does your lab
diagnose each year?
Would your lab be willing to participate in a necropsy-based study to
assess the carrier state of leptospires in healthy adult horses?

139

APPENDIX 4
AAVLD Accredited Laboratories*
State
Alabama
Arizona
California
Colorado
Connecticut

Serovar

Canicola, Hardjo, Pomona, Grippotyphosa,
Icterohaemorrhagiae
Send Out
Canicola, Hardjo, Pomona, Bratislava,
Grippotyphosa, Icterohaemorrhagiae
Canicola, Hardjo, Pomona, Bratislava,
Grippotyphosa, Icterohaemorrhagiae

Canicola, Hardjo, Pomona, Grippotyphosa,
Florida
Icterohaemorrhagiae
GeorgiaCanicola, Hardjo, Pomona, Bratislava,
Athens
Grippotyphosa, Icterohaemorrhagiae
Canicola, Hardjo, Pomona, Bratislava,
Georgia-Tifton Grippotyphosa, Icterohaemorrhagiae,
Autumnalis
Canicola, Hardjo, Pomona, Bratislava,
Illinois
Grippotyphosa, Icterohaemorrhagiae,
Autumnalis
Canicola, Hardjo, Pomona, Bratislava,
Indiana
Grippotyphosa, Icterohaemorrhagiae,
Autumnalis
Canicola, Hardjo, Pomona, Bratislava,
Iowa
Grippotyphosa, Icterohaemorrhagiae
Canicola, Hardjo, Pomona, Bratislava,
Kansas
Grippotyphosa, Icterohaemorrhagiae
KentuckyCanicola, Hardjo, Pomona, Grippotyphosa,
Lexington
Icterohaemorrhagiae
KentuckyCanicola, Hardjo, Pomona, Bratislava,
Murray
Grippotyphosa, Icterohaemorrhagiae, (Other)
Canicola, Hardjo, Pomona, Bratislava,
Louisiana
Grippotyphosa, Icterohaemorrhagiae
Canicola, Hardjo, Pomona, Bratislava,
Michigan
Grippotyphosa, Icterohaemorrhagiae
Canicola, Hardjo, Pomona, Grippotyphosa,
Minnesota
Icterohaemorrhagiae, Bratislava
MississippiStarkville-Refer to TVMDL
Starkville/Pearl Pearl-PCR
Canicola, Hardjo, Pomona, Bratislava,
Missouri
Grippotyphosa, Icterohaemorrhagiae
Canicola, Hardjo, Pomona, Bratislava,
Montana
Grippotyphosa, Icterohaemorrhagiae,
Autumnalis
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PCR

FA

IHC

Yes
Yes
Yes
Yes
Yes

Yes
Yes

Yes

Yes

Yes
Yes

Yes

Yes

Yes

Yes
Yes
Yes
Yes

Yes

Yes
Yes
Yes

Nebraska
New YorkIthaca
North
CarolinaRaleigh
North Dakota
Ohio
Oklahoma
PennsylvaniaNew Bolton
PennsylvaniaPSU
PennsylvaniaPVL
South Dakota
Texas-College
Station
Texas-Canyon
Utah-Logan
VirginiaBlacksburg
WashingtonPullman
WashingtonPuyallup
WisconsinMadison
WisconsinBarron
Wyoming

*Current-2021

Canicola, Hardjo, Pomona, Grippotyphosa,
Icterohaemorrhagiae, Bratislava
Canicola, Hardjo, Pomona, Grippotyphosa,
Icterohaemorrhagiae/Copenhageni
Canicola, Hardjo, Pomona, Grippotyphosa,
Icterohaemorrhagiae, Autumnalis, Bratislava
Canicola, Hardjoprajitno, Pomona, Bratislava,
Grippotyphosa, Icterohaemorrhagiae
Canicola, Hardjo, Pomona, Bratislava,
Grippotyphosa, Icterohaemorrhagiae
Canicola, Hardjo, Pomona, Grippotyphosa,
Icterohaemorrhagiae (either Autumnalis or
Bratislava); Canine-does all 7
Canicola, Hardjo, Pomona, Grippotyphosa,
Icterohaemorrhagiae (either Autumnalis or
Bratislava); Canine-does all 7
Canicola, Hardjo, Pomona, Bratislava,
Grippotyphosa, Icterohaemorrhagiae
Canicola, Hardjo, Pomona, Bratislava,
Grippotyphosa, Icterohaemorrhagiae,
Autumnalis, Sejroe
Canicola, Hardjo, Pomona, Bratislava,
Grippotyphosa, Icterohaemorrhagiae,
Autumnalis, Sejroe
Nothing listed on test/fee pdf (lcrvth@vt.edu)
Canicola, Hardjo, Pomona, Bratislava,
Grippotyphosa, Icterohaemorrhagiae (Canine
additionally Autumnalis)
Avian only
Canicola, Hardjo, Pomona, Bratislava,
Grippotyphosa, Icterohaemorrhagiae (will also
run Autumnalis and Sejroe)
Probably Madison only but didn’t list
Canicola, Hardjo, Pomona, Grippotyphosa,
Icterohaemorrhagiae
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Map of AAVLD Locations and Leptospiral Tests

Microagglutination Test (MAT)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
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APPENDIX 6
Induction Pathways of HO-1*

AP-1, Nrf2 and NF-κB are localized in cytosol under normal conditions. Under
stress, they are activated and translocate to the nucleus. In the nucleus they bind
specifically to the DNA sequence which leads to the HO-1 transcription.
*Waza, A. A.: Z. Hamid, S. Ali, S. A. Bhat, and M. A. Bhat, M. A review on heme
oxygenase-1 induction: is it a necessary evil. Inflamm Res, 2018. 67: p. 579-588.
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